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A CLINICOPATHOLOGICAL STUDY TO ANALYSE THE IMPORTANCE OF 
HISTOPATHOLOGICAL EXAMINATION IN DIAGNOSIS OF EXCISED 
CONJUNCTIVAL LESIONS OF BULBAR CONJUNCTIVA 
INTRODUCTION 
The conjunctiva is readily visible and so the tumors and other lesions in the conjunctiva are 
generally recognized at an early stage. Clinical diagnosis can often be made by ocular 
examination and slit- lamp bio microscopy, if features are characteristics. A biopsy is not 
necessary in cases of smaller tumors that appear benign. Small tumours can be better 
removed completely in one setting (excisional biopsy). Larger lesions, remove a portion of 
the tumor (incisional biopsy) to get a histopathologic diagnosis prior to more extensive 
therapy.It is rarely needed to do exfoliative cytology or  fine- needle aspiration biopsy, as 
incisional biopsy is readily available.  Slit- lamp examination of the cornea is needed in 
patients with suspected conjunctival tumors. Rule out any corneal involvement in squamous 
cell carcinoma and melanoma of conjunctiva before planning for surgery. 
ANATOMY OF CONJUNCTIVA: 
The conjunctiva has 3 geographic zones: palpebral, forniceal, bulbar. The palpebral 
conjunctiva starts from the mucocutaneous junction of lid and covers the inner surface of lid 
and attached firmly to the tarsus. The tissue is freely movable in the fornices, in the upper lid 
it is enmeshed with fibrous elements of the levator aponeurosis and Muller muscle. In the 
lower lid, fibrous expansions from the inferior rectus muscle join with the inferior tarsal 
muscle. The bulbar conjunctiva is freely mobile.It fuses with the Tenon capsule and gets 
inserted into the limbus. Blood supply to the bulbar conjunctiva is by anterior ciliary arteries 
and to the tarsal conjunctiva is by branches of the marginal arcades of lids. The proximal 
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arcade, along the upper border of the lid, gives branches proximally to the forniceal and the 
bulbar conjunctiva via the posterior conjunctival arteries. The ciliary arteries via the anterior 
conjunctival arteries gives the limbal blood supply. The innervation of the conjunctiva is 
from the ophthalmic division of trigerminal nerve. 
The conjunctiva is a mucous membrane made of non-keratinizing squamous epithelium with 
lot of goblet cells and richly vascularized substantia propria having lymphatic vessels, plasma 
cells, macrophages, mast cells. A lymphoid layer is presents from the bulbar conjunctiva to 
sub tarsal folds.Specialized aggregations of conjunctiva-associated lymphoid tissue (CALT) 
correspond to mucosa associated lymphoid tissue (MALT) and have collections of T and B 
lymphocytes under the epithelium. They help in antigen processing. The conjunctival 
epithelium is 2 to 5 cells thick. The basal cells are cuboidal in shape and become flattened 
polyhedral cells at the surface. The goblet cells (mucous glands) are found in the inferior and 
medial part of the conjunctiva more in the region of the caruncle and plica semilunaris. They 
are sparsely found in the remainder of the conjunctiva and absent in the limba1 area. 
FIGURE 1: HISTOLOGY OF CONJUNCTIVA 
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MANAGEMENT 
Management of a conjunctival tumor may be 
• serial observation 
• incisional biopsy 
• excisional biopsy 
• cryotherapy 
• chemotherapy 
• radiotherapy 
• modified enucleation 
• orbital exenteration or 
• Various combinations of the above. 
If large conjunctival defect present-mucous membrane grafts of the other eye 
conjunctiva, buccal mucosa, amniotic membrane graft may be done. 
Observation 
Most benign lesions like pingueculum, dermolipoma, and nevus are just observed. Anterior 
segment slit lamp photos are taken for photographic evidence for follow up every 1 year to 
look for any growth, malignant transformation, or compression on normal surrounding 
tissues. 
Incisional Biopsy 
For suspicious lesion like squamous cell carcinoma, PAM, melanoma, and conjunctival 
spread of sebaceous gland carcinoma if these tumours occupy >4 clock hours in conjunctiva. 
For larger lesions incisional wedge biopsy or punch biopsy done. Treatment planned based on 
biopsy reports. 
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Excisional Biopsy 
In Intermediate and small tumors that are symptomatic or suspected to be malignant, 
excisional biopsy is preferred over incisional biopsy to avoid inadvertent tumor seeding. 
Excision biopsy needed in  limbal dermoid, epibulbar osseous choristoma,  steroid- resistant 
pyogenic granuloma, squamous cell carcinoma, and melanoma.in lesions of conjunctival 
fornix it is totally excised and the conjunctiva reconstructed with absorbable sutures , fornix 
deepening sutures, symblephron ring used. If defect is large mucous membrane graft used. 
Most malignant tumours are limbal in location. Limbal neoplasms invades the corneal 
epithelium, sclera, anterior chamber and the soft tissues of the orbit. If sclera is involved thin 
sclera biopsy taken to achieve tumour clearance. Friable tumors may cause seeding of tumour 
and so “no touch technique” followed. 
SURGICAL TECHNIQUE OF EXCISION BIOPSY: 
Done under microscope 
The operative field should be left dry 
Avoid wetting the field with balanced salt solution to prevent seeding of cells. Retrobulbar 
anesthesia used 
The corneal epithelial component is approached first and the conjunctival component is 
dissected next so that the whole specimen resected in one piece. Absolute alcohol in an 
applicator is gently applied to the entire corneal component. Epithelial cellular devitalization 
and easy release of the tumor cells from Bowman’s. 
The malignancy outlined with beaver blade using a delicate epithelial incision or 
epitheliorhexis technique 2 mm outside the corneal component. 
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With the beaver blade the corneal epithelium is sweeped from centre to limbus. A pentagonal 
or circular conjunctival limbal based incision is made outside the tumor margin. 
The incision is carried through the underlying Tenon’s fascia until the sclera is seen and full 
thickness conjunctiva and Tenon’s fascia is included into the excisional biopsy. Cautery done 
to control bleeding. A second incision outlined by a superficial scleral groove approximately 
0.2 mm in depth and 2.0 mm outside the base of the overlying adherent conjunctival mass. 
This groove is continued anteriorly up to the limbus. This area outlined by the scleral groove 
is cut by flat dissection of about 0.2-mm thickness within the sclera in an attempt to remove a 
superficial lamella of sclera, overlying Tenon’s fascia and conjunctiva with tumor- free 
margins is removed in one piece without touching the tumor itself (no- touch technique). The 
removed specimen is held flatly on a piece of cardboard from the surgical tray and kept in 
fixative and given for histopathologic studies. This prevents the specimen from folding and 
so helps in better assessment of the tumor margins .Now new set of instruments used, to 
avoid contamination of healthy tissue with possible tumor cells. After excision of the 
specimen, cryotherapy is applied to the margins of the remaining bulbar conjunctiva. This is 
performed by freezing the surrounding bulbar conjunctiva by lifting it away from the sclera 
using the cryoprobe. When the ice ball reaches a size of 4 to 5 mm, it is allowed to thaw and 
the cycle repeated once. The cryoprobe is then moved to an adjacent area of the conjunctiva 
and the cycle is repeated until all of the margins have been treated by this method. Corneal 
margins need not be treated with cryoapplication. The tumor bed treated with absolute 
alcohol wash on cotton- tip applicator and bipolar cautery, to avoid direct cryotherapy to the 
sclera. Using clean instruments, the conjunctiva is then mobilized for closing the defect by 
making the intermuscular septum loose with Steven’s scissors spreading and creating Trans 
positional conjunctival flaps. Closure is done with interrupted absorbable 6–0 or 7–0 sutures. 
An area of bare sclera can be left close to the limbus, but complete closure is better as this 
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promotes better healing and helps in further surgery in case the patient develop recurrence. 
The patient is given topical antibiotics and corticosteroids for 2 weeks and followed up at 3- 
to 6-month intervals. 
Cryotherapy 
In the management of conjunctival tumors, cryotherapy can be used as a supplemental 
treatment. It can eliminate microscopic tumor cells and prevent recurrence of malignant 
tumors. It can also be used as a mainstay of treatment for primary acquired melanosis and 
pagetoid invasion of sebaceous gland carcinoma. If cryotherapy can devitalize the malignant 
or potentially malignant cells, radical surgery like orbital exenteration can be avoided. 
Chemotherapy 
Topical eyedrops composed of mitomycin C, 5-fluorouracil, interferon, or cidofovir are 
effective in treating epithelial malignancies such as squamous cell carcinoma, primary 
acquired melanosis, and pagetoid invasion of sebaceous gland carcinoma. 
Mitomycin C or 5-fluorouracil are employed most successfully for squamous cell carcinoma, 
especially after tumor recurrence following previous surgery. This medication is prescribed 
topically four times daily for a 1-week period followed by a 1-week hiatus to allow the ocular 
surface to recover. This cycle is repeated once again so that most patients receive a total of 2 
weeks of the chemotherapy topically. Both mitomycin C and 5-fluorouracil are most effective 
for squamous cell carcinoma and less for primary acquired melanosis and pagetoid invasion 
of sebaceous gland carcinoma. Toxicities include most commonly dry- eye findings, 
superficial punctate epitheliopathy, and punctal stenosis. Corneal, scleral melt, and cataract 
can develop if these agents are used with open conjunctival wounds or used more. Topical 
interferon can be effective for squamous epithelial malignancies and is less toxic to the 
surface epithelium, but this medication may require many months of use to effect a result. 
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Other topical antiviral medications including cidofovir can be employed with little toxicity 
for squamous epithelial tumors. 
Radiotherapy 
Two forms of radiotherapy are employed for conjunctival tumors, namely external beam 
radiotherapy and custom designed plaque radiotherapy. External beam radiotherapy to a total 
dose of 3000 to 4000 cGy is used to treat conjunctival lymphoma and metastatic carcinoma if 
lesions are too large or diffuse to excise locally. Side effects are dry eye, punctate epithelial 
abnormalities, and cataract. Custom- designed plaque radiotherapy to a dose of 3,000 to 
4,000 cGy can be used to treat conjunctival lymphoma or metastasis. A higher dose of 6,000 
to 8,000 cGy can be employed to treat the more radiation- resistant melanoma and squamous 
cell carcinoma. The two designs for conjunctival custom plaque radiotherapy include a 
conformer plaque technique with six fractionated treatment sessions or a reverse plaque 
technique with the device sutured onto the episclera. Plaque radiotherapy to a low dose of 
2,000 cGy is employed for benign conditions such as steroid resistant pyogenic granuloma 
that show recurrence after surgical resection. 
Modified Enucleation 
Modified enucleation is a treatment modality for primary malignant tumors of the conjunctiva 
that have invaded through the limbal tissues into the globe, causing secondary glaucoma. The 
mucoepidermoid variant of squamous cell carcinoma of the conjunctiva has a greater 
tendency for such invasion. At the time of enucleation, it is necessary to remove the involved 
conjunctiva intact to avoid spreading tumor cells. Thus, the initial peritomy should begin at 
the limbus, but when the tumor is approached, the incision should proceed posteriorly from 
the limbus to surround the tumor- affected tissue by at least 3 to 4 mm. The tumor will 
remain adherent to the globe at the limbus. Sometimes a suture is employed through the 
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surrounding conjunctiva into the episclera to secure the tumor to the globe. The remaining 
steps of enucleation are gently performed .The globe is removed with tumor adherent after 
cutting the optic nerve from the nasal side. The margins of the remaining, unaffected 
conjunctiva are treated with double freeze thaw cryotherapy.Residual conjucnctiva present 
for closure. A mucous membrane graft or amniotic membrane graft may be necessary for 
adequate closure and to provide fornices for a prosthesis. A simple horizontal inferior 
forniceal conjunctival incision from canthus to canthus may suffice, as long as the conformer 
is constantly worn as a template so the new conjunctival fornix grows deep and around this 
structure. 
Orbital Exenteration 
Orbital exenteration is the treatment of choice for primary malignant conjunctival tumors 
with orbital involvement. Either an eyelid- removing or eyelid- sparing exenteration is done, 
depending on the extent of eyelid involvement. The  eyelid- sparing technique is done due to 
better cosmetic appearance and they heal within 2 or 3 weeks.If the anterior lamella of the 
eyelid is uninvolved with tumor, an eyelid- sparing  (eyelid- splitting) exenteration may be 
accomplished . 
Mucous Membrane Graft 
Mucous membrane grafts are occasionally necessary to replace vital conjunctival tissue after 
removal of extensive conjunctival tumors. The best donor sites include the forniceal 
conjunctiva (ipsilateral or contralateral eye) and buccal mucosa from the posterior aspect of 
the lower lip or lateral aspect of the mouth. Such grafts are removed by a freehand technique, 
fashioned to fit the defect, and fit into place with cardinal and running absorbable 6–0 or 7–0 
sutures. The tissue is delivered frozen and must be defrosted for 20 minutes. The fine, 
transparent material is carefully peeled off its cardboard surface, laid basement membrane 
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side up, and sutured into place with absorbable sutures. Topical antibiotic and steroid 
ointments are applied following all conjunctival grafting procedures. For graft harvest and 
placement, the surgeon should always use clean, sterile instruments at both the donor and the 
recipient sites. Free tumor cells can rest on instrument tips and later implant and grow in 
previously uninvolved areas if such precautions are not taken. 
I.CONGENITAL LESIONS 
A variety of tumors and related conditions may be present at birth and become clinically 
apparent shortly after birth. Most of the lesions are choristomas, consisting of tissue elements 
that are not normally present at the involved site. 
DERMOID 
Conjunctival dermoid is a congenital well- circumscribed yellow- white solid mass that 
involves the bulbar conjunctiva or at the corneoscleral limbus. It occurs near the limbus 
inferotemporally, and often this tumor has fine hairs, best seen with slit- lamp biomicroscopy. 
It may extend to the central cornea or be located in other quadrants on the bulbar surface. It 
may be an isolated lesion or can be associated with Goldenhar’s syndrome. The patient 
should be evaluated for ipsilateral or bilateral preauricular skin appendages, hearing loss, 
eyelid coloboma, and orbitoconjunctival dermolipoma, and cervical vertebral anomalies that 
comprise this uninheritable syndrome. 
Histopathologically, the conjunctival dermoid is a choristomatous malformation that is made 
up of dense fibrous tissue lined by conjunctival epithelium with dermal elements like hair 
follicles and sebaceous glands. The management of dermoid includes observation if the 
lesion is small and visually non symptomatic. We can excise the lesion for cosmetic reasons, 
but the remaining corneal scar may be cosmetically unacceptable. Larger and symptomatic 
dermoids can cause visual loss from astigmatism. These can be managed by lamellar 
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keratosclerectomy and primary closure of overlying tissue if the defect is superficial or 
closure with corneal graft if the defect is deep or full thickness. The cosmetic appearance may 
improve, but the refractive and astigmatic error and visual acuity may not change .When the 
lesion is in the central cornea, a lamellar or penetrating keratoplasty may be needed and long- 
term amblyopia may be a problem. Rarely, extensive dermoids involve the lateral canthus, 
and planned excision with lateral canthal repair is necessary. 
FIGURE 2: DERMOID – GROSS AND HISTOPATHOLOGICAL APPERANACE 
 
DERMOLIPOMA 
Dermolipoma is congenital and present at birth, but it remains asymptomatic and may not be 
detected till adulthood, till it protrudes from the orbit from the conjunctival fornix 
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superotemporally. It appears as a pale yellow, soft, fluctuant, fusiform mass from the 
palpebral lobe of the lacrimal gland, best visualized with the eye in inferonasal gaze. 
It extends for a variable distance into the orbital fat and on the bulbar conjunctiva, and 
occasionally it can extend anteriorly till the limbus. Unlike herniated orbital fat, dermolipoma 
can contain fine white hairs on its surface and it could not be reduced with digital pressure 
into the orbit. In computed tomography (CT) or magnetic resonance imaging (MRI), 
dermolipoma is similar to orbital fat. Histopathologically, it is lined by conjunctival 
epithelium on the surface and the subepithelial tissue has collagenous connective tissue. Most 
of dermolipomas need no treatment, but larger symptomatic ones and cosmetically 
unappealing can be managed by excision of the whole orbitoconjunctival lesion through a 
conjunctival forniceal approach or simply removing the anterior part of lesion similar to 
removal of prolapsed orbital fat. 
FIGURE 3: DERMOLIPOMA – GROSS AND HISTOPATHOLOGICAL 
APPEARANCE 
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EPIBULBAR OSSEOUS CHORISTOMA 
Epibulbar osseous choristoma is a rigid deposit of bone generally seen in the bulbar 
conjunctiva superotemporal quadrant. It is congenital and typically remains undetected till 
personally palpated by the patient. It is clinically rock- hard consistency on palpation, though 
fibrous tissue tumors can be similar. The diagnosis can be made with USG or CT to illustrate 
the calcium component. This tumor is managed by periodic observation. Sometimes patients 
have a foreign- body sensation, and such lesions can be excised with a circumtumoral 
conjunctival incision followed by dissection to bare sclera and full- thickness conjunctival 
resection done. For tumors that are adherent to the sclera, a superficial sclerectomy might be 
needed. 
LACRIMAL GLAND CHORISTOMA 
Lacrimal gland choristoma is a congenital lesion in young children as an asymptomatic pink 
stromal mass, mostly in the inferior bulbar or forniceal conjunctiva. It is found that this lesion 
presents in this location due to the pathway the lacrimal gland takes during embryogenesis 
from the inferior to superotemporal region. The lacrimal gland choristoma can mimic a focus 
of inflammation because of its pink color.A cystic appearance comes from this secretory 
mass if there is no attachment to the conjunctival surface. Excisional biopsy is usually done 
to confirm the diagnosis. 
RESPIRATORY CHORISTOMA 
Rarely a cystic choristoma, appearing as congenital sclerocorneal ectasia, is noted 
COMPLEX CHORISTOMA 
The conjunctival dermoid and epibulbar osseous choristoma are simple choristomas as they 
have one tissue type, such as skin or bone. A complex choristoma has a variety of tissue, such 
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as dermal appendages, lacrimal gland tissue, cartilage and bone. It has variable in its clinical 
appearance and may cover epibulbar surface or form a circumferential growth pattern around 
the limbus. The complex choristoma has association with the linear nevus sebaceous of 
Jadassohn which has the cutaneous features such as sebaceous nevus in the facial region and 
neurologic features such as seizures, mental retardation, arachnoid cyst, and cerebral atrophy. 
The ophthalmic features of this syndrome are epibulbar complex choristoma and posterior 
scleral cartilage. The management of the complex choristoma is dependent on the extent of 
lesion. Observation and wide local excision with mucous membrane graft reconstruction may 
be done. In extensive lesion, where the lesion causes dense amblyopia and no hope for visual 
acuity, modified enucleation and ocular surface reconstruction may be done. 
II. BENIGN TUMORS OF SURFACE EPITHELIUM 
PAPILLOMA 
Squamous papilloma is a benign tumor that originates from human papillomavirus infection 
of conjunctiva. This tumor can occur in children and adults, and has a pink fibrovascular 
frond of tissue arranged in a sessile or pedunculated pattern. In children, the lesion is small, 
multiple, and found in the inferior fornix. In adults, it is solitary, more extensive, and extend 
to cover the full corneal surface resembling malignant squamous cell carcinoma. 
FIGURE 4: PAPILLOMA – GROSS AND HISTOPATHOLOGICAL APPEARANCE 
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KERATOACATHOMA 
The conjunctiva can produce benign reactive inflammatory lesions that resemble carcinoma 
such as pseudocarcinomatous hyperplasia and variant, keratoacanthoma. Sometimes a distinct 
nodule may be found. This lesion appears gelatinous or leukoplakic, similar to squamous cell 
carcinoma of conjunctiva, but its onset is more rapid. Acanthosis, hyperkeratosis, and 
parakeratosis are seen histopathologically. 
HEREDITARY BENIGN INTRAEPITHELIAL DYSKERATOSIS 
Hereditary benign intraepithelial dyskeratosis (HBID) is a condition seen in isolate of 
Caucasians, African Americans, and American Indians. It is an AD disorder and has bilateral 
elevated fleshy plaques on nasal or temporal perilimbal conjunctiva. Similar plaques can be 
seen on buccal mucosa. It can remain asymptomatic or can cause severe redness and foreign 
body sensation. Sometimes it can extend onto the cornea. 
DACRYOADENOMA 
Dacryoadenoma is a rare tumor, seen in children or young adults as a pink mass in inferior 
bulbar or palpebral region. It is uncertain if it is congenital or acquired. This benign tumour 
originates from the surface epithelium and proliferate to the stroma, forming glandular 
lobules. 
KERATOTIC PLAQUE 
Keratotic plaque is white limbal or bulbar conjunctival mass, seen in the interpalpebral region 
made of acanthosis and parakeratosis and keratinization of the epithelium. It is similar to 
squamous cell carcinoma with leukoplakia. 
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ACTINIC KERATOSIS 
Actinic keratosis is a frothy, white lesion seen over a chronically inflamed pingueculum or 
pterygium. Histopathologically, it is made of a proliferation of surface epithelium with 
keratosis. Clinically, it is similar squamous cell carcinoma of the conjunctiva. 
III. MELANOCYTIC TUMORS 
Tumors arise from the melanocytes of the conjunctiva and episclera .Benign pigmented 
lesions include conjunctival nevus and racial melanosis. Ocular melanocytosis, a benign 
pigmentation of the sclera, is misdiagnosed as a pigmented lesion of the conjunctiva. 
Malignant or potentially malignant pigmented lesions include primary acquired melanosis 
and malignant melanoma 
MELANOSIS 
Epithelial Melanosis 
Epithelial/ racial melanosis of the conjunctiva is a primary melanotic condition affecting 
blacks more than whites. Racial melanosis appears in early childhood and stabilizes in early 
adulthood. Flat patches of pigment are scattered in the conjunctival epithelium, mostly in the 
interpalpebral and perilimbal areas. Both eyes are affected, the amount of pigment may be 
asymmetric. The lesions fade near the fornices.Due to their intraepithelial location, these 
pigmented lesions are freely mobile over the globe. The pigmentation extend into the 
peripheral cornea and may be pronounced around the perforating branches of the anterior 
ciliary nerves. Histopathologic examination of epithelial melanosis shows an increased 
deposition of melanin granules in basal layer of the conjunctival epithelium. The conjunctival 
epithelium has normal morphology and maturation. The pigment does not extend than the 
basal epithelium and has no cellular atypia. 
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Epithelial melanosis is benign. Treatment is periodic observation. Care taken to distinguish 
racial melanosis and primary acquired melanosis, especially in dark pigmented patients, in 
whom distinction is difficult. Biopsies are useful to confirm the histopathologic diagnosis. 
FIGURE 5: BENIGN MELANOSIS – HISTOPATHOLOGICAL APPEARANCE 
 
SUBEPITHELIAL MELANOCYTOSIS 
Clinical Presentation 
Subepithelial (congenital) melanocytosis of the deep conjunctiva, episclera or superficial 
sclera is congenital condition that is common in African Americans, Asians, and Hispanics. 
The pigmented lesions appear bluish or slate-gray and usually unilateral. These lesions are 
deep and immobile. The overlying conjunctiva is unpigmented. The melanocytosis may 
affect the uvea, meninges, and soft tissues of orbit. Ipsilateral dermal melanocytosis in 
distribution of the ophthalmic and maxillary branches of trigeminal nerve is found in 
approximately 50% of patients with congenital melanocytosis. This is known to as 
oculodermal melanocytosis or nevus of Ota . 
Histopathology 
The classic histopathologic finding is focal proliferation of subepithelial melanocytes. These 
melanocytes are elongated and fusiform with prominent branching processes than the 
melanocytes in nevi. 
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FIGURE 6: SUBEPITHELIAL MELANOSIS – GROS AND HISTOPATHOLOGICAL 
APPEARANCE 
 
Treatment and Prognosis 
The prognosis is good.But white patients with lesion have more risk of developing uveal 
melanoma. Glaucoma with hyperpigmentation of the trabecular meshwork develops in about 
10% of patients. Yearly ophthalmic review is needed. 
CONJUNCTIVAL NEVI 
Classification and Clinical Presentation 
Nevi are common lesions of conjunctiva. Their colour may be from tan to dark brown. 30%, 
however, may be light pigmented or nonpigmented. Pigmentation increases during puberty, 
and nonpigmented lesions can become pigmented, and seems as if the lesion has grown. Nevi 
can be congenital, but commonly arise during childhood or adulthood. Like skin nevi, 
conjunctival nevi are classified by layer in which they are seen into intraepithelial 
(junctional), compound, or subepithelial type of nevi. It is tough to distinguish layer involved 
on clinical examination alone. Nevi have little/ no malignant potential. Conjunctival nevi are 
solitary, well-circumscribed, flat/ raised, brown, pigmented, free mobile lesions most 
commonly found near the limbus. 
Nevi can be focal or diffuse, but never multifocal. Many nevi have small cysts. Blue nevi are 
deeper, localized, have palpable thickness, and more cellular. They are gray or blue in colour 
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and appear early in childhood. Blue nevi are benign, but have malignant potential if they are 
hypercellular. Split nevus of the eyelid, may be found with malignant melanoma of the 
conjunctiva. 
FIGURE 7: CONJUNCTIVAL NEVI – GROSS AND HISTOPATHOLOGICAL 
APPEARANCE 
 
Histopathologic examination of conjunctival nevi has spindle-shaped or multipolar dendritic 
cells with fine melanin granules (nevus cells). The location of these cells detects if the nevus 
is junctional, subepithelial, or compound. In junctional, nests of nevus cells are present at the 
junction between the epithelial and subepithelial tissues. Junctional nevi may be tough to 
differentiate from PAM with atypia or melanomas histologically. Junctional nevi usually 
occur during childhood and pagetoid (intraepithelial) spread does not occur usually. 
Compound nevi of the conjunctiva show nevus cells within and beneath the epithelium. In 
subepithelial nevi, the cells are beneath the epithelium. Another variant, the combined nevus, 
is contains blue nevus and a junctional, compound, or subepithelial nevus. The blue nevus 
part of a combined nevi is smaller and deeper than other component. 
Treatment and Prognosis 
Nevi are benign and most do not need treatment or surgical excision. Sometimes nevi may be 
inflamed and exhibit times of rapid growth causing the clinical suspicion of malignancy. The 
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rapid growth occurs around puberty and most commonly found in compound nevi near the 
limbus. Patients with allergies can be prone. Histopathology shows the benign, inflammatory 
nature of nevi. Nevi of the palpebral conjunctiva, fornix, caruncle, and cornea should be 
suspicious of being malignant and an excisional biopsy needed. 
PRIMARY ACQUIRED MELANOSIS 
Clinical Presentation 
PAM of the conjunctiva made of unilateral, multiple, flat, indistinct areas of golden to dark 
brown colour with irregular margins. The size and colour of PAM lesions changes over time. 
The lesions are freely mobile and involve any part of the conjunctiva. Slit-lamp 
biomicroscopy, includes lid eversion with careful inspection of the palpebral conjunctiva. 
Double eversion of the upper lid is needed to see the entire upper fornix. The lacrimal gland 
and lacrimal sac may be involved rarely by PAM. PAM is common in middle-aged /elderly 
whites and is rare in blacks of all ages. The prevalence of PAM in the general population 
ranges from 10% to 36%. The melanosis in PAM is due to an increase in melanin production 
(with or without melanocytosis). Malignant transformation of PAM lesions occurs when 
histologic atypia is present. 50% of patients with PAM with atypia may transform to 
melanoma. This rate is 90% for lesions that have epithelioid cells or a pagetoid growth. 
Malignant transformation is suspected in enlarging, highly vascularized lesions, and lesions 
more than 7.5 to 10 mm, or in lesions having patchy pigmentation. Development of nodules 
in a previously flat lesion is an ominous sign. 
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FIGURE 8: PAM – GROSS AND HISTOPATHOLOGICAL APPEARANCE 
 
Histopathology 
Clinical features cannot distinguish precancerous PAM (with histologic atypia) and benign 
PAM without atypia. Suspicious lesions, should undergo an excisional biopsy, because this is 
the only way to find the presence or absence of atypia. Lesions without histologic atypia 
never become malignant. Histologically, PAM lesions without atypia may have increased 
melanin production with or without melanocytosis. The melanocytosis is restricted to the 
basilar regions of conjunctival epithelium. Nuclear hyperchromasia is absent and nucleoli are 
not prominent. Patients with PAM without atypia tend are younger than patients with PAM 
and atypia. PAM without atypia become PAM with atypia. PAM with atypia has an increased 
chance of malignant transformation. Five patterns of atypical cells have been described with 
different rates of progression to melanoma. These are small polyhedral cells, spindle cells, 
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large dendritiform melanocytes, epithelioid, or polymorphous (mixture). The atypia degree 
increases with size of the nucleus and prominence of nucleoli. Lesions composed of 
epithelioid cells or showing pagetoid spread have highest rate of malignant transformation. 
Immunohistostaining with the monoclonal antibodies MIB-1 and PC-10 staining for the 
proliferation markers Ki-67 and the proliferating cell nuclear antigen (PCNA), may help 
differentiate between PAM with / without atypia. 
Treatment and Prognosis 
Complete excision of all lesions with atypia is goal of treatment, obtaining tumor-free 
margins. In diffuse PAM, excision of any nodular areas is important. Multiple map biopsies 
of the conjunctiva, and areas where there is no pigment, is needed in assessing the extent of 
the disease. Cryotherapy, radiotherapy, or topical mitomycin C are useful adjunctives. 
Topical mitomycin C is useful in patients with diffuse disease, with the entire ocular surface. 
Extensive cryotherapy of the limbus can affect the stem cell population. Cryotherapy causes 
necrosis of anterior segment. Six weekly cycles of topical mitomycin C 0.04% has good 
response, ] but cytologic changes in the conjunctiva mimicking malignancy after giving 
topical 0.02% to 0.04% mitomycin C drops is also noted. These changes localized to the 
superficial layers of the conjunctival epithelium and include enlarged nucleus, chromatin 
smudging-hyperchromasia, cytoplasmic eosinophilia, single cell necrosis, and subepithelial 
inflammation. Primary acquired melanosis can recur after excision, and new lesions develop 
elsewhere on the conjunctiva. Due to risk of malignant transformation and the possibility of 
recurrences after excision, patients with PAM should have careful ocular examination and 
documentation and cervical LN status. 
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IV. VASCULAR TUMORS 
PYOGENIC GRANULOMA 
Pyogenic granuloma is proliferative fibrovascular response to tissue insult by either 
inflammation, surgery, or any nonsurgical trauma. It is classified as a polypoid form of 
acquired capillary hemangioma. It appears as an elevated red mass, often with a good blood 
supply. Microscopically, it is composed of “granulation tissue” with chronic inflammatory 
cells and small calibre blood vessels. As the lesion is neither pyogenic nor granulomatous, the 
name pyogenic granuloma is a misnomer. Pyogenic granuloma responds to topical 
corticosteroids, but most cases ultimately require surgical excision. In recurrence, low- dose 
plaque radiotherapy can be applied. 
FIGURE 9a: PYOGENIC GRANULOMA – GROSS AND HISTOPATHOLOGICAL 
APPEARANCE 
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FIGURE 9b: PYOGENIC GRANULOMA – GROSS AND HISTOPATHOLOGICAL 
APPEARANCE 
 
CAPILLARY HEMANGIOMA 
Capillary hemangioma of conjunctiva generally occurs in infancy, or several weeks following 
birth, as red stromal mass, associated with cutaneous / orbital capillary hemangioma. The 
conjunctival mass may enlarge over several months and spontaneously involute. Management 
–observation, surgical resection /local /systemic prednisone can be given. 
FIGURE 10 – CAPILLARY HEMANGIOMA – GROSS APPEARANCE 
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CAVERNOUS HEMANGIOMA 
Cavernous hemangioma is rare. This benign tumor is a red or blue lesion in the deep stroma 
in young children. It is similar to the orbital cavernous hemangioma that is diagnosed in 
young adults.Managed by local resection. 
RACEMOSE HEMANGIOMA 
Dilated arteriovenous communication without intervening capillary bed (racemose 
hemangioma) is found in conjunctiva. It remains stable for years and is monitored 
conservatively. Rule out Wyburn- Mason syndrome in these cases. 
LYMPHANGIOMA 
Conjunctival lymphangioma can occur as isolated conjunctival lesion or, is a superficial 
component of deeper diffuse orbital lymphangioma .It becomes clinically apparent in first 
decade and appears as multiloculated mass containing variable- sized clear dilated cystic 
channels .Blood is seen in most of the cystic space called “chocolate cysts.” The treatment of 
conjunctival lymphangioma is difficult because surgical resection or radiotherapy cannot 
eradicate the mass. 
FIGURE 11 – GROSS APPEARANCE OF LYMPHANGIOMA 
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VARIX 
Varix is a venous malformation found in orbit and the conjunctiva. It is a mass of dilated 
venous channels that enlarges with Valsalva manoeuvre. Treatment is cautious observation. If 
painful, cold compresses and aspirin may be used. Surgical resection should be cautious due 
to the risk for prolonged bleeding. 
HEMANGIOPERICYTOMA 
Hemangiopericytoma is made of pericytes that surround blood vessels. It shows both benign 
and malignant cytologic features. Appears as a red conjunctival mass originating from the 
stroma. Wide surgical resection with tumor- free margins is needed. 
KAPOSI’S SARCOMA 
Kaposi’s sarcoma is a cutaneous malignancy that occurs in elderly /immunosuppressed 
patients.This tumor has become more common in AIDS and affects mucous membranes, such 
as conjunctiva. Clinically it appears as reddish vascular masses that resembles a hemorrhagic 
conjunctivitis. It is moderately responsive to chemotherapy and marked response to low- dose 
radiotherapy. 
FIGURE 12: KAPOSI SARCOMA – GROSS AND HISTOPATHOLOGICAL 
APPEARANCE 
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V. FIBROUS TUMORS 
FIBROMA 
Fibroma is a rare conjunctival tumor which appears as a white stromal mass, unifocal or 
multifocal. Surgical resection is needed. 
Fibrous Histiocytoma 
It is a rare mass of the conjunctiva and made of fibroblasts and histiocytes. Clinically and 
histopathologically it is similar to many other amelanotic stromal tumors. In the conjunctiva 
it may be benign, locally invasive, or malignant. Wide excision with tumor- free margins is 
needed. 
NODULAR FASCIITIS 
It is a benign proliferation of connective tissue that commonly occurs in the skin and lesser in 
the eyelid, orbit, and conjunctiva. Clinically and histopathologically it resembles fibro 
sarcoma. The lesion is a solitary white mass in Tenon’s fascia. Complete excision is needed 
as the lesion tend to recur. 
VI. NEURAL TUMORS 
Neural tumors of the conjunctiva are rare. They manifest a more yellow appearance than 
fibrous tumors. 
NEUROFIBROMA 
It can occur in the conjunctiva as solitary /a diffuse / plexiform variety. The former is not 
associated with systemic conditions and the latter is a part of von Recklinghausen’s 
neurofibromatosis. The solitary tumor is slowly enlarging raised stromal mass that is 
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managed by complete surgical resection. The plexiform type is difficult to surgically excise, 
and debulking procedures are necessary. 
FIGURE 13: NEUROFIBROMA – GROSS APPEARANCE 
 
NEURILEMOMA 
Also known as schwannoma, is a benign proliferation of Schwann cells surrounding the 
peripheral nerves. This tumor commonly from the orbit, rare in the conjunctiva. Clinically, 
this lesion is   yellowish- pink, nodular mass in conjunctival stroma. Complete excision is 
needed. 
GRANULAR CELL TUMOR 
It is a rare tumor it is of Schwann cell origin. This benign tumor and clinically appears 
smooth, vascular, and pink, and located in the stroma or within Tenon’s fascia. 
Histopathologically, it is made of large round cells with granularity to the cytoplasm. 
Complete excision is needed. 
VII. HISTIOCYTIC TUMORS 
XANTHOMA 
Xanthoma most common in the cutaneous dermis, near extensor surfaces and on the 
conjunctiva it is rare. Conjunctival xanthoma is a yellow subepithelial smooth mass affecting 
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epibulbar surfaces. Bilateral conjunctival involvement has been noted and is termed 
xanthoma disseminatum. Histopathologically, subepithelial infiltrate - lipidized histiocytes/, 
eosinophils, / Touton giant cells are noted. 
JUVENILE XANTHOGRANULOMA 
It is a relatively common cutaneous condition that is painless, pink skin papules with 
spontaneous resolution, in children under the age 2 years. Conjunctival, orbital, and 
intraocular involvement is seen. The conjunctival mass appears as an orange- pink stromal 
mass, typically in young adults. If the classic skin lesions are present, treatment with 
observation or topical steroid ointment is provided. Else, biopsy is needed, and recognition of 
the typical histopathologic features of histiocytes admixed with Touton’s giant cells helps to 
confirm the diagnosis. 
RETICULOHISTIOCYTOMA 
It is a rare tumor, seen as part of a systemic multicentric reticulohistiocytosis. Clinically, the 
tumor is seen as a pink, vascular limbal mass in adult. Histopathologically, it is made of large 
histiocytes with granular cytoplasm. 
VIII. MYXOID TUMORS 
MYXOMA 
Myxoma is a rare tumor that appears as orange- pink mass within stroma. This is associated 
with Carney complex, a syndrome of cardiac / systemic myxomas, cutaneous lentigines, and 
Sertoli cell tumor of testicles. Histopathology shows slender stellate and spindle cells 
interspersed in loose stroma. 
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IX. LIPOMATOUS TUMORS 
LIPOMA 
It is rare and generally is found in adults as  yellowish- pink stromal mass.Most are the 
pleomorphic type having large lipid vacuoles surrounded by stellate cells. 
FIGURE 14 – LIPOMA – GROSS APPEARANCE 
 
HERNIATED ORBITAL FAT 
Orbital fat presents in the conjunctiva as a herniation from superotemporal orbit. The 
condition is bilateral and represents deficiency in orbital connective tissue to maintain the 
proper location of orbital fat. Clinically, it is deep to Tenon’s fascia and is prominent on 
inferonasal gaze. Digital reposition of the fat into the orbit is possible, but only temporary. 
Management is observation.If dry eye occurs resection of the herniated fat and resuspension 
of the orbit position of the fat is done. Histopathologically, the tissue is made of large lipid 
cells. 
LIPOSARCOMA 
It has been rarely seen and shows features similar to lipoma. Histopathologically, neoplastic 
stellate lipid cells and “signet- ring” type cells have been seen. 
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X. LYMPHOID TUMORS 
Lymphoid tumors can be isolated lesions or manifestation of systemic lymphoma. 
Clinically, appears as a diffuse, slightly elevated pink mass in the stroma or deep to Tenon’s 
fascia, most common in the forniceal region. This is similar to the smoked salmon; and so 
called the “salmon patch”. It is tough to differentiate between a benign and malignant 
lymphoid tumor.So, biopsy is needed to establish the diagnosis, and systemic evaluation 
needed in all affected patients to exclude the possibility of systemic lymphoma. 
Histopathologically, “sheets of lymphocytes” are found & classified as reactive lymphoid 
hyperplasia or malignant lymphoma. Mostly they are B- cell lymphoma (non- Hodgkin’s 
type). Rarely T- cell lymphoma is seen .Treatment of the conjunctival lesion includes 
chemotherapy if systemic lymphoma is present or external beam irradiation (2,000 to 4,000 
cGy) if it is localized to the conjunctiva. Other options are excisional biopsy & cryotherapy, 
local interferon injections/ observation. 
FIGURE 15: LYMPHOMA – GROSS AND HISTOPATHOLOGICAL APPEARANCE 
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XI. LEUKEMIA 
Leukemia manifests in the ocular region as hemorrhages due to anemia and 
thrombocytopenia rather than leukemic infiltration.Leukemic infiltration can be found with 
CLL. The tumor appears as a pink smooth mass in the conjunctival stroma at the limbus/ the 
fornix, similar to a lymphoid tumor. Biopsy shows sheets of large leukemic cells. Treatment 
of the systemic condition is needed with secondary resolution of conjunctival infiltration. 
XIII. METASTATIC TUMORS 
These rarely occur in the conjunctiva, can be from breast carcinoma, cutaneous melanoma, 
and other primary tumors. Metastatic carcinoma is one or more fleshy pink vascularized 
conjunctival stromal masses. Metastatic melanoma to the conjunctiva is pigmented. 
XIV. SECONDARY CONJUNCTIVAL INVOLVEMENT FROM ADJACENT 
TUMORS 
The conjunctiva may be secondarily involved by adjacent structures tumours, by direct 
extension from tumors of eyelids. The most important tumor causing is sebaceous gland 
carcinoma of the eyelid. This shows pagetoid invasion & extends into the conjunctival 
epithelium & causes clinical picture similar to chronic unilateral blepharoconjunctivitis. 
Uveal melanoma in the ciliary body can go extrasclerally to the subconjunctival tissues, 
producing a primary conjunctival tumor. Rhabdomyosarcoma of orbit, a tumor found in 
children, presents first with conjunctival lesion before the orbital mass is discovered. 
XV. CARUNCULAR TUMORS AND CYSTS 
The caruncle is a unique that contains elements of conjunctiva and skin. The tumors in the 
caruncle are similar to those in mucous membranes and skin. By histopathologic, 95% 
caruncular tumors are benign and 5% are malignant. The most common lesions are papilloma 
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and nevus. Other lesions are pyogenic granuloma, inclusion cyst, and sebaceous hyperplasia, 
& sebaceous adenoma, oncocytoma. Malignant tumors like squamous cell carcinoma, 
melanoma, lymphoma, & sebaceous carcinoma are rare in the caruncle. The oncocytoma is 
benign tumor occurs more commonly in lacrimal / salivary glands. In caruncle it arises from 
accessory lacrimal gland tissue &often has a blue cystic appearance.  The treatment of 
caruncular masses is observation / local resection 
XVI. OTHER MISCELLANEOUS LESIONS THAT CAN SIMULATE 
CONJUNCTIVAL NEOPLASMS 
A few nonneoplastic conditions can be similar to neoplasms. These include pinguecula, 
pterygium, foreign body, inflammatory granuloma, amyloidosis. In most cases, the history 
and clinical finding, and in some excision of the mass may help to exclude a neoplasm. 
XVII. DEGENERATIONS 
PINGUECULA AND PTERYGIUM 
A pinguecula is small, yellowish nodule, bilateral and located at the nasal / temporal limbus. 
A manifestation of actinic damage “exposure to sunlight” or environmental factors, like dust 
and wind, ageing- this growth is more common. On histology, the stromal collagen has 
fragmentation and basophilic degeneration known as elastotic degeneration as the 
degenerated collagen stains positively when using histochemical stains for elastic fibre like 
the Verhoeff–van Gieson stain. A pterygium is like the pinguecula in etiology & location but 
differs in its invasion of the ‘superficial cornea’ as a vascular, wing-shaped growth. Histology 
shows elastotic degeneration; prominent blood vessels may be seen if vascularity seen 
clinically and variable amount of chronic inflammation. Recurrent pterygia may not have 
histologic feature of elastotic degeneration and are exuberant fibroconnective tissue response. 
In pingueculae and pterygia overlying epithelium may show mild squamous metaplasia. 
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Thus, with actinic damage to the skin, there is the possibility for future malignant 
transformation, though this occurs in rare cases with pingueculae and pterygia. If conjunctival 
squamous neoplasia occurs, it occurs over an area of preexisting elastotic degeneration. If 
epithelial hyperplasia, nuclear hyperchromasia and pleomorphism, & excess mitotic figures 
are seen in an excised pinguecula or pterygium, a diagnosis of OSSN should be assigned. 
FIGURE 16: PINGECULA GROSS APPEARANCE 
 
 
SENILE SCLERAL PLAQUES 
These occur in the sclera rather than the cornea / conjunctiva. These lesions areYellow, gray, 
/black vertical bands anterior to insertion of the medial & lateral rectus muscles in elderly. 
They are more common after 60 years, like pinguecula and pterygium, may be due to UV 
exposure. Histologically, calcium deposits with reduced cellularity and hyalinization are 
seen. They do not need therapy 
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FIGURE 17: SENILE SCLERAL PLAQUE – GROSS AND HISTOPATHOLOGICAL 
APPEARANCE 
 
AMYLOID DEPOSITS 
It is most commonly an idiopathic localized process in healthy young and middle-aged adults. 
They are typically made of monoclonal immunoglobulin “AL amyloid” produced by local 
clonal plasma cells. Conjunctival amyloidosis is due to long-standing inflammation, like with 
trachoma (AA amyloid). Conjunctival amyloidosis may occur in primary conjunctival 
lymphoma /plasmacytoma (or) secondary to systemic lymphoma / plasma cell myeloma. 
Clinically, conjunctival amyloidosis seen as a salmon-coloured nodule which is associated 
with hemorrhage. Histologically, appears as eosinophilic extracellular deposits in the stroma,   
in a perivascular distribution. On Congo red stain, under standard light, amyloid deposits are 
seen orange. When viewed with polarized light & rotating polarization filter, they exhibit 
birefringence. Other useful staining methods -crystal violet and the fluorescent stain 
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thioflavin. Electron microscopy shows fibrils. Immunohistochemical methods, sequencing & 
mass spectrometry–based proteomic analysis are used in amyloid subtyping. 
FIGURE 18: AMYLOID DEPOSITIS – GROSS AND HISTOPATHOLOGICAL 
APPEARANCE 
 
EPITHELIAL INCLUSION CYST 
This may form at a site of previous accidental / surgical trauma (like after strabismus surgery, 
retinal surgery, or enucleation). Clinically, it is a transparent, cystic elevation on the ocular 
surface with associated injection. Histologic examination shows cystic space lined by 
conjunctival epithelium in the stroma. The lumen may be empty / have inspissated 
proteinaceous material & cellular debris. 
FIGURE 19: EPITHELIAL INCLUSION CYST – GROSS AND 
HISTOPATHOLOGICAL APPEARANCE 
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XVIII. GRANULOMATOUS CONJUNCTIVITIS 
It is less common than papillary conjunctivitis and follicular conjunctivitis and has infectious 
and non-infectious causes. Clinically, the nodular elevations of granulomatous conjunctivitis 
is tough to distinguish from follicles, but the history and systemic symptoms may help in the 
diagnosis. Granulomatous conjunctivitis with preauricular lymphadenopathy is known as 
“Parinaud oculoglandular syndrome”. Bacteria like Bartonella henselae (causing cat-scratch 
disease) & Francisella tularensis (causing tularemia), mycobacteria (Mycobacterium 
tuberculosis), treponemes (syphilis), and fungi (sporotrichosis) may cause. Microorganisms 
may be seen with Gram, acidfast / silver stains. The diagnosis is based on the culture results, 
serology, PCR, or combination of all. If biopsy is done, the granulomas in granulomatous 
conjunctivitis will show central necrosis. In non-infectious cause of granulomatous 
conjunctivitis like sarcoidosis, involve all ocular tissues, also the conjunctiva. It occurs as 
small tan nodules with no inflammatory signs, within the fornix. Conjunctival biopsy is a 
simple way of giving diagnostic confirmation of systemic disease. Histologically, 
noncaseating granulomatous “tubercles” are seen within the conjunctival stroma, with a 
minimal cuff of lymphocytes & plasma cells. The diagnosis of sarcoidosis is made if 
supported by clinical features and infectious causes of granulomatous inflammation have 
been ruled out by histochemical and by culture results. 
FOREIGN BODY GRANULOMA 
Since it is exposed surface, the conjunctiva is open to contact with foreign bodies. Some are 
transient & inert, others may become embedded and cause a foreign-body reaction, seen 
histologically as granuloma around the foreign object. Multinucleated giant cells are seen. 
Viewing the tissue section under polarized light may be useful in identifying the offending 
foreign object. 
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FIGURE 20: FOREIGN BODY GRANULOMA – GROSS AND 
HISTOPATHOLOGICAL APPEARANCE 
 
SARCOID GRANULOMA 
FIGURE 21: SARCOID GRANULOMA – GROSS AND HISTOPATHOLOGICAL 
APPEARANCE 
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XIX. MALIGNANT LESIONS: 
CONJUNCTIVAL- INTRAEPITHELIAL NEOPLASIA (CIN) AND SQUAMOUS 
CELL CARCINOMA (NON PIGMRNTED) 
Epithelial neoplasia of the ocular surface is a disease complex, having a spectrum of changes 
within the epithelial layers. Previously known as Bowen’s disease and ocular surface 
squamous neoplasia. Conjunctival- corneal intraepithelial dysplasia (CCIN) is used if the 
cornea is also involved. The earliest change is dysplasia, limited by the underlying epithelial 
basement membrane. Increasing degrees of dysplasia occurs if process is not stopped 
resulting in transgression of the basement membrane and invasion of underlying space & 
structures. This invasion of subjacent tissue is hallmark of squamous cell carcinoma. 
Histologic examination is needed for definitive diagnosis. 
 
FIGURE 22: DIAGRAMMATIC REPRESENTATION OF HISTOPATHOLOGY OF 
VARIOUS CONJUNCTIVAL NEOPLASIA 
 
Incidence and Etiology 
CIN occurs in elderly, with   light- complexioned men having extensive actinic exposure... 
The incidence of SCC of the eye has been calculated to increase 49% for every 10-degree 
decrease in latitude. Previous H/O skin cancer is positive prognostic indicator for CIN. Apart 
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from ultraviolet light, other reported risk factors are previous H/O skin cancer, smoking, 
ocular trauma, petroleum derivative exposure. Human papilloma virus (HPV), types 16 and 
18, has been found in conjunctival epithelial neoplasia by immunohistochemical and other 
molecular analysis. The role of HPV in the etiology of CIN is unclear. Atypical, rapidly 
progressive CIN in younger patients is associated with HIV. CIN has been found in younger 
organ transplant patients using long- term cyclosporine. Xeroderma pigmentosum is an AR 
disorder characterized by inadequate repair of DNA damage due to ultraviolet radiation. 
Affected patients are prone to epithelial cancers, those of the conjunctiva & cornea. The 
limbus is the transitional zone, from columnar conjunctival to stratified squamous corneal 
epithelium. Within crypts of Vogt are the limbal stem cells. This area is similar to the uterine 
cervix. Similar to cervical tissue, the corneal limbus is the site of origin for the majority of 
dysplastic & neoplastic changes of the ocular surface. 
Clinical Presentation 
The patient with CIN presents with ocular irritation /complaints of redness /“growth on the 
eye.” Vision is not affected. Differentiation of benign from malignant surface tumors is 
difficult in slit lamp examination even for the experienced. Examination reveals a vascular 
limbal mass, within interpalpebral area. The affected area is thick, and may appear gelatinous 
/velvety. Gelatinous thickening, with superficial blood vessels, is common. CIN may mimic 
diffuse chronic conjunctivitis with mild thickening. Other less common presentations are 
sclerokeratitis, which is a focal corneal or scleral thinning with inflammation without any 
tumor mass. Sclerokeratitis is similar to interstitial keratitis or Mooren’s ulcer. Biopsy is 
needed in atypical /chronic scleritis / conjunctivitis unresponsive to standard treatment. 
Hyperkeratosis is a characteristic feature of CIN and manifest as a white surface plaque, / 
“leukoplakia”, which has no diagnostic significance. Neoplastic cells invades corneal 
epithelium, as a continuation of limbal CIN. Neoplastic cells may originate at the limbus and 
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migrate centrally.  Affected epithelium looks translucently gray, with sharply demarcated 
border.  Finger- like protrusions, and isolated islands are found on the leading edge. The 
epithelium inside the lesion is thickened, and blood vessels are present, especially close to 
limbus. Spontaneous regression may occur. 
Marked thickening of a limbal lesion and fixation of the mass to underlying tissue, suggests 
squamous cell carcinoma. Biopsy  may yield helpful diagnostic information. In exfoliative 
cytology and impression cytology, superficial cells are removed, fixed and stained with a 
Papanicolaou technique, and studied by a cytopathologist. In exfoliative cytology cells are 
taken away with a sterile platinum spatula, but in impression cytology cells are retained in 
cellulose acetate paper strips, that are pressed against the area in doubt. Cells are graded on 
degree of atypia, (including size, shape, nuclear and nucleolar characteristics, and mitotic 
figures). Cytology is positive in 77% of biopsy- proven cases. 
Differential Diagnosis 
i) Benign epithelial lesion– associated thickening and surface keratin. 
ii) Irritation caused by stromal inflammation or by pinguecula or pterygia may cause 
pseudoepitheliomatous hyperplasia, and thickening of the epithelium and leukoplakia. Biopsy 
reveals the benign acanthosis and hyper keratosis without dysplasia. Simple excision is done. 
iii) Actinic keratosis of the ocular surface is due to UV radiation. These lesions occur in 
older, light complexioned people with previous exposure to sunlight, the same population at 
higher risk for CIN. Thickening with hyperkeratosis is present. Histopathologic examination 
may show, mild acanthosis with hyperkeratosis &inflammation, to marked acanthosis with 
cellular pleomorphism. 
iv) Benign conjunctival papillomas, 
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v) Chronic conjunctivitis 
vi) Inflammation of a pinguecula or pterygium 
FIGURE 23: OSSN – GROSS IMAGE 
 
Pathology 
Histologic examination is needed for definitive diagnosis.In small lesion, excisional biopsy 
and removal of the entire mass is done. Incisional biopsy of the atypical area is performed for 
larger lesions. Staining with hematoxylin- eosin and PAS is sufficient for the diagnosis of 
CIN lesions. Biopsy helps to determine the depth of the lesion, & whether the margins are 
free of tumor. The transition from normal to abnormal epithelium is sudden. 
Specimens are graded based on location and degree of atypia. 
Full- thickness dysplasia indicates carcinoma- in- situ. 
Extension of tumour to sub epithelial space (substantia propria, sclera, or cornea) indicates 
squamous cell carcinoma. Advanced tumors may enter into ciliary body, iris, and trabecular 
meshwork. 
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Mucoepidermoid carcinoma is uncommon in the conjunctiva. Clinically it is difficult to 
differentiate from CIN. Histopathology shows epidermoid and   mucus- secreting cells. 
Special stains for mucin, like Alcian blue / mucicarmine are used in diagnosis.As 
mucoepidermoid carcinoma of the conjunctiva is locally aggressive than CIN, this diagnosis 
needs proper follow up for invasion and recurrence. 
Spindle cell carcinoma is aggressive variant of conjunctival squamous cell carcinoma arising 
on the ocular surface. Clinical differentiation of this tumor is difficult. Pathologically, 
pleomorphic spindle cells are seen, arranged in fascicles. Immuno histochemical analysis 
using cytokeratin stains demonstrates the epithelial origin of spindle cell carcinoma. 
Transmission electron microscopy may be used in difficult cases. 
FIGURE 24: OSSN – GROSS AND HISTOPATHOLOGICAL IMAGE 
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Treatment 
Surgical excision of suspicious area is the approach to therapy, if the entire lesion can be 
removed in toto. Staining with rose Bengal will highlight abnormal epithelium. A wide 
margin of 2 to 3 mm around the visible tumor is seen. 
Frozen section control can shoe lateral surgical margins, not helpful with the deep margins. 
Cryotherapy with a nitrous oxide probe done after surgical excision decreases the recurrence 
rate of CIN. After removal of the lesion with 2- to 3-mm free margins, freezing the remaining 
conjunctival margins and the sublesional base is done with formation of ice ball for 6 
seconds, followed by slow thaw. A double freeze- thaw technique is usually done; but three 
cycles are better if inadequate removal of tumor is suspected. Cryotherapy destroys tumor 
cells by ‘thermal disruption’ & resultant local ischemia. Side effects of cryotherapy are 
elevation or decrease in IOP, corneal scarring, iris atrophy, and destruction of retina. Local 
application of beta- irradiation is used as primary treatment of squamous epithelial tumors, & 
treatment of incompletely excised squamous tumors. Other side effects of irradiation are dose 
related and include cataract, secondary glaucoma, local scarring, dry eye, & loss of cilia. The 
threshold dose to prevent cataract of surface strontium 90 is estimated to be 5,000 rads. 
Therapy with antimetabolite agents is beneficial in the adjunctive treatment of partially 
excised corneal epithelial neoplasia & initial therapy in recurrent disease, extensive disease 
having ill- defined borders/ situations in which excessive conjunctiva may be taken off, 
leading to severe dry eye /limbal stem cell deficiency. “The rationale is use the highest 
possible dose against the smallest amount of tumor”. Both MM-C and 5-FU have a selective 
effect on rapid growing tumor cells. Due to   dose- related local toxicity, intervening rest 
periods between topical chemotherapy are employed. Rest intervals spares the limbal stem 
cells. Punctal plugs needed to protect the NL system during therapy to reduce systemic 
absorption, or manual punctal occlusion may be done after each dose of drug. The ability of 
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topical treatment to eradicate tumor cells located in the subepithelial space is an area of 
concern in possible squamous cell carcinoma with scleral invasion.  Long- term observation 
is needed, as squamous cell carcinoma may recur. Mitomycin C (MMC) is a 
chemotherapeutic antibiotic from Streptomyces caespitosus, which is used as an alkylating 
agent and inhibits DNA synthesis. MMC also has an effect on fibroblasts and stem cells. 
Therapeutic applications include 0.02% or 0.04% MMC QID for 14-day courses; 0.02% 
MMC TDS for 14 days; and 0.04% MMC QID for 1 week cycles. A combination of excision, 
cryotherapy, and topical MMC is effective in recurrent CIN. Adverse reactions to topical 
drug mild hyperemia and tearing, photophobia, hyperemia, PEK, and blepharospasm. Pain 
occurs if used more than 14 days; stoppage of therapy leads to decrease of pain. More severe 
side effects, including scleral ulceration and perforation. 5--FU drug has antimetabolite 
properties, rapidly growing cells accumulate lethal amounts of 5-FU. 5-FU is useful as an 
adjunct in recurrent or incompletely excised squamous cell carcinoma. 1% 5-FU in artificial 
tear base TDS- QID daily for 2- to 3-week cycles, until epithelium sloughs off. Clinical 
improvement or resolution of intraepithelial neoplasia seen in all cases. 
Recombinant interferon- alfa-2b 
It has been used successfully in the treatment of CCIN, with an initial injection of 3 million 
international units (IU), followed by “topical” interferon- alfa-2b drops (1 million IU/mL) 
QID daily. If clinical response was noted by 1 week, topical therapy was continued until 
resolution of the CIN. If response  seen at 1week, subconjunctival and perilesional injections 
are given three times weekly until clinical resolution. No complications seen with topical 
therapy, though fever and myalgia may occur with subconjunctival dose. 
Intralesional interferon alfa-2b is also successful in the treatment of squamous cell and basal 
cell carcinoma of the skin. The mechanism is unknown. Regression occurred after 6 weeks of 
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topical therapy with cidofovir (2.5 mg/mL), one drop 2 hourly initially, with a weekly taper 
in frequency over the next 6 weeks. A residual focus needed excision, followed by 
cryotherapy. If spread to the regional lymph node occurs, radical neck dissection may be 
done 
Prognosis 
Conjunctival CIN, including squamous cell carcinoma, is a low- grade malignancy. 
Recurrence is by the integrity of surgical margins, so need for wide margins and 
histopathologic examination is stressed. The degree of histologic atypia and presence of 
subepithelial neoplastic cells (squamous cell carcinoma) corresponds to recurrence rate. The 
majority of neoplasia recur before 2 years, though recurrences have occurred as late of 5 
years after excision. Intraocular invasion in 3% to 11% of patients with conjunctival SCC. 
The mucoepidermoid variant is aggressive and invades adjacent tissues. Extension of 
squamous cell carcinoma commonly affects the sclera, anterior chamber, trabecular 
meshwork, ciliary body, and choroid. If globe is invaded iridocyclitis, ciliary body elevation, 
and secondary glaucoma occurs. Orbital invasion seen in 11% to 15% of invasive SCC of the 
conjunctiva. Exenteration is needed in cases involving the orbit. Conjunctival squamous cell 
carcinoma may metastasize to the preauricular and cervical LN, with an incidence of 0 to 4%. 
Metastases to the parotid gland, lungs and bone occur rarely. 
SEBACEOUS CARCINOMA 
Etiology and Incidence 
Sebaceous carcinomas occur from adnexal epithelium of sebaceous glands throughout the 
body. The ocular adnexa contributes for 25% of sebaceous carcinoma and is the common 
locale for these tumors. Sebaceous carcinomas may occur in the meibomian glands of the 
tarsus, the glands of Zeiss at the lid margin, & sebaceous glands of the caruncle or 
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surrounding skin / eyebrow. The most common adnexal site is the meibomian glands of the 
upper and lower lids. Meibomian glands are larger compared to the sebaceous glands 
elsewhere & not associated with hair follicles. Sites of sebaceous carcinoma- meibomian 
glands, glands of Zeiss, & caruncle, eyebrows, eyelids. Other sites include -external genitalia, 
parotid and submandibular glands, external auditory canal, and the trunk and upper extremity. 
Older patients are more commonly affected, with diagnosis usually between the 5 th and 9 th 
decade of life, though cases in children have been reported .Sebaceous carcinoma in younger 
patients with HIV virus have been noted. 
Sebaceous carcinoma may occur postradiation treatment for other tumors 
Clinical Presentation 
Sebaceous carcinoma may occur in a variety of ways, mimicking common conditions and 
delaying diagnosis. The usual presentation is that of a painless, slowly progressive mass 
arising within the eyelid. The upper lid is most commonly involved. Ulceration of the eyelid 
skin typically occurs late, unlike basal cell or squamous cell carcinomas, although ulceration 
may occur earlier in cases originating near the lid margin. Sebaceous carcinoma may cause 
atrophy and loss of lashes. A yellow tint is found in some cases. The eyelid tumor may 
remain relatively small, whereas intraepithelial spread of tumor cells leads to inflammation of 
the ocular surface. Thus, sebaceous carcinoma may resemble benign conditions such as 
conjunctivitis, blepharoconjunctivitis, blepharitis, superior limbic keratoconjunctivitis, and 
keratitis .Symblepharon formation and corneal neovascularization may occur. Sebaceous 
carcinoma presenting as a papillary growth of the palpebral conjunctiva has been described. 
Sebaceous carcinoma of the eyelid may be thought as a chalazion. Chalaza tend to occur 
rapidly, whereas sebaceous carcinoma is slowly progressive. Helpful differentiating signs in 
carcinoma include adhesion of the skin to a firm underlying mass, erythema, trichiasis, 
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destruction of the cilia, and conjunctival cicatrization. Growth or spread of a localized 
carcinoma may conceivably be facilitated by inappropriate incision and curettage. A 
longstanding recommendation has been to perform a full- thickness eyelid biopsy for all 
recurrent eyelid masses originally felt to be a chalazion. Clear communication by the surgeon 
of any suspicion or concern for sebaceous carcinoma to the ophthalmic pathologist is 
important... 
Pathology 
Sebaceous carcinoma requires biopsy for definitive diagnosis. Any suspicion of sebaceous 
carcinoma by the surgeon should be communicated to the ophthalmic pathologist, as special 
preparation of the specimen is required. Routine processing of formalin- fixed tissue will 
remove intracellular lipid; fresh frozen sections, however, will preserve this lipid, which can 
then be stained with oil red- O or other fat stains to facilitate diagnosis. Difficulties may arise 
in pathologic diagnosis of sebaceous carcinoma, as well as in clinical diagnosis. It is most 
frequently misdiagnosed as basal cell carcinoma or squamous cell carcinoma. Unlike these 
epithelial tumors, sebaceous carcinoma will often have an identifiable site of origin deeper 
within the eyelid.  Well- differentiated tumors are composed of pleomorphic cells with foamy 
or vacuolated cytoplasm. Fresh frozen sections stained with oil red- O or other fat stains will 
demonstrate lipid within the cytoplasm. Less differentiated neoplasms contain less lipid and a 
more basophilic cytoplasm, as well as mitotic figures. These cells may be mistaken for basal 
cell carcinoma.Such tumors may simulate squamous cell carcinoma. Intraepithelial 
carcinomatous change may occur in either eyelid skin or conjunctiva, or in both. Individual 
cells or small clusters may be found within epithelium. This pattern is called “pagetoid” 
spread, as it resembles intraepithelial spread in Paget disease of the breast. Intraepithelial 
involvement may also resemble severe dysplasia or squamous carcinoma- in- situ, replacing 
the entire epithelium with malignant sebaceous cells. Intraepithelial involvement was noted in 
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44% of 104 specimens and in 50% of 40 specimens. Severe chronic inflammation is usually 
present, correlating with the clinical inflammation seen in cases mimicking chronic 
blepharitis, conjunctivitis, or keratitis. The various clinical and pathologic presentations of 
intraepithelial sebaceous carcinoma illustrate the necessity of full- thickness eyelid biopsy to 
find the underlying tumor. Excision of skin or conjunctiva only may lead to erroneous 
diagnosis. Cases of sebaceous pagetoid spread without underlying eyelid tumor have been 
reported. One possible reason for this phenomenon is regression of the original tarsal tumor. 
Residual nests of sebaceous carcinoma in areas of tarsus with fibrosis and inflammation seen 
in some cases lend support to this explanation. 
EVALUATION OF A PATIENT WITH SEBACEOUS CARCINOMA 
If sebaceous carcinoma is confirmed by biopsy, a complete history, family history, physical 
examination, and complete eye examination is indicated. The family history should be 
inquired about benign or malignant skin lesions, as well as internal malignancies that 
characterize Muir- Torre syndrome. Complete evaluation of the skin for other cutaneous 
tumors as well as palpation of the lymph nodes should be performed. Baseline studies include 
chest x- ray, liver function tests, and complete blood count. If the clinician suspects the 
possibility of Muir- Torre syndrome, further testing includes rectal examination, 
colonoscopy, and barium enema. Mammography may be needed. 
Treatment 
Wide surgical excision with eyelid reconstruction is the primary treatment for sebaceous 
carcinoma of the eyelid. The goal is to obtain 5- to 6-mm surgical margins clear of tumor by 
fresh frozen tissue control. If the conjunctiva is involved, map biopsies to determine the 
presence and extent of pagetoid spread is useful. As originally described by Putterman, local 
anesthesia of the eyelids as well as palpebral and bulbar conjunctiva is achieved with 2% 
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lidocaine with epinephrine. Biopsies of conjunctiva and underlying tarsus are obtained from 
the temporal, central, and nasal areas of the upper and lower eyelids, as well as temporal, 
central, and nasal bulbar conjunctiva.  Full- thickness excision of the eyelid in any involved 
area is then performed under frozen section control, with 5-mm normal margins. Adjunctive 
cryotherapy to areas of affected conjunctiva has been described in six patients. In each case 
wide resection of the eyelid was followed by cryotherapy to affected conjunctiva as 
determined by mapping. A concern of any technique using representative biopsies is failure 
to diagnose clinically inapparent areas of involvement. Mohs micrographic surgery (MMS) of 
eyelid sebaceous carcinoma has been described, with primary repair of the ensuing eyelid 
defect by an oculoplastic surgeon. Spencer and colleagues reported a recurrence rate of 11% 
in 18 patients with an average follow- up of 37 months. Radiation therapy is considered 
palliative and not curative in sebaceous carcinoma... If diffuse spread into both eyelids is 
found, and extension into the orbit, orbital exenteration is recommended. A limited orbital 
exenteration with removal of eyelid, conjunctival sac, globe, and tenonectomy has been 
described for sebaceous carcinoma with pagetoid spread to conjunctiva and cornea. Biopsy 
should be performed if the ipsilateral parotid or cervical lymph nodes are enlarged, because 
inflammation alone may cause this change. If the lymph nodes contain tumor cells, radical 
neck dissection, superficial parotidectomy, and postoperative radiation have been 
recommended. Chemotherapy has also been used for recurrent sebaceous carcinoma. 
Prognosis 
5-year mortality rate of 30%. A number of factors, including delay in diagnosis, tumor 
location and size, and pathologic features, have been associated with a poorer prognosis. 
Pathologic features associated with a poor prognosis included multicentric origin, poor 
degree of differentiation, highly infiltrative pattern, intraepithelial carcinoma, invasion of 
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vascular or lymphatic channels, and extension into the orbit. Metastases may occur in the 
ipsilateral parotid and cervical lymph nodes, as well as in lungs, liver, brain, bone. 
CONJUNCTIVAL MELANOMA 
Clinical Presentation 
The term melanoma was first introduced by Carswell in 1838. These uncommon lesions 
make up less than 1% of all ocular malignancies and only 2% to 5% of all ocular melanomas. 
Conjunctival melanomas are less common than uveal and skin melanomas.The increased 
incidence of conjunctival melanomas may be due to increased sun exposure. Malignant 
melanomas of the uvea and conjunctiva are histopathologically and clinically different and 
therefore should be considered separate entities. In fact, melanomas of the conjunctiva have 
more in common with melanomas of the skin than with melanomas of the uveal tract. 
Conjunctival melanomas are extremely rare in blacks and Asians. They usually develop after 
the third decade of life. The mean age at diagnosis is 52 to 60 years. In most series, males and 
females are equally affected. Conjunctival melanomas in children are also very rare. 
Approximately 75% of conjunctival melanomas arise from pre-existing PAM. The rest occur 
de novo, from a nevus or a blue nevus, or secondary to metastasis from a melanoma 
elsewhere. A rare aggressive form of amelanotic melanoma arises from PAM without 
pigmentation (“sine pigmento”). Chronic exposure to ultraviolet radiation has been 
implicated in the etiology of conjunctival melanomas. Several case reports have described 
conjunctival and uveal melanomas in patients with the dysplastic nevus syndrome of the skin, 
suggesting an association between these malignancies. The “dysplastic nevus syndrome 
“consists of atypical cutaneous nevi, which may be sporadic or familial. This skin nevus has a 
typical clinical appearance, but nuclear atypia is found on histologic exam. Conjunctival 
malignant melanoma lesions are nodular. They may invade the globe or extend posteriorly 
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into the orbit. Some lesions are pedunculated. Multicentric cases have been reported. 
Pigmentation is variable and are heavily vascularized. The bulbar conjunctiva and limbus are 
the most commonly involved sites. Primary malignant melanoma of the cornea is extremely 
rare. Most melanomas of the cornea, however, are secondary to extension from the 
neighbouring conjunctiva and usually involve the superficial layers of the cornea anterior to 
the basement membrane. 
Histopathology 
Histopathology of malignant melanomas of the conjunctiva reveals four different cell types: 
-small polyhedral cells 
-spindle cells 
- Balloon cells and 
-round epithelioid cells. 
Lesions composed mostly of spindle cells have the lowest potential for metastasis. 
Prognosis and Metastatic Potential 
The overall 10 year survival rate following conjunctival melanoma varies from 70% to 87%. 
Risk factors for death from tumor metastasis include a lump as the presenting symptom, a 
melanoma arising de novo, and the technique of initial surgery. Prognosis also depends in 
part on the location of the lesion and its cytologic characteristics. Bulbar conjunctival 
melanomas -favourable prognosis than palpebral conjunctival tumors or tumors involving the 
fornix or caruncle. Large, multicentric, thick, or recurrent tumors, pagetoid growth, and 
lymphatic invasion increased risk for metastasis. Tumors composed mostly of spindle cells 
have a better prognosis than those composed of mixed cell types. Up to 30% to 40% of 
tumors metastasize at an average of 3.2 years after initial diagnosis. Risk factors for 
52 
 
metastasis include tumor location away from the limbus and lateral tumor margin 
involvement on pathologic examination .Metastasis is related to the presence of PAM sine 
pigmento, forniceal, palpebral, or caruncular location, lesion thickness of more than 2 mm, 
and histologic evidence of intralymphatic spread. Metastasis of conjunctival melanomas 
occurs through the lymphatics to regional lymph nodes especially the parotid (preauricular) 
and submandibular nodes. Palpation of these areas is an important part of the follow up of 
patients with conjunctival melanoma. Once metastasis has occurred, the survival rate declines 
markedly. Sentinel lymph node mapping and selective lymphadenectomy may help detect 
early metastasis. Local intraocular extension of tumor may occur, although this is infrequent 
FIGURE 25: CONJUNCTIVAL MELANOMA – GROSS AND HISTOPATHOLOGICAL 
APPEARANCE 
 
Treatment 
In the past, melanomas of the conjunctiva were considered so malignant, and their behaviour 
so unpredictable, that orbital exenteration was commonly performed even for small lesions. 
Currently, therapy involves less drastic approaches. If a melanoma is confirmed on 
histopathologic analysis, complete excision with cryotherapy of the conjunctival margins and 
scleral base should be performed. 
The surgical technique used to manage conjunctival melanomas is important, as incomplete 
tumor removal increases the risk of recurrence. In general, one should avoid incisional 
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biopsies when a lesion is suspicious for malignant melanoma as this can lead to “seeding” of 
tumor cells onto the conjunctival surface. Complete surgical excision of nodular or 
vascularized conjunctiva with superficial lamellar dissection of underlying sclera for adherent 
tumors, using the “no-touch” technique decreases recurrences, tumor cell seeding, and 
metastasis. A 3- to 5-mm tumor-free margin is ideal. Cryotherapy, using a double freeze-thaw 
approach, can be applied to the cut edges of conjunctiva and to the scleral base at the time of 
excision. Extension of tumor cells onto the cornea, which is usually superficial and does not 
penetrate Bowman’s membrane, can be managed using alcohol-assisted epithelial removal. 
One should avoid penetrating Bowman’s layer during surgery, as this layer serves as a natural 
barrier against tumor extension into the corneal stroma. Map biopsies of surrounding PAM 
and even of uninvolved conjunctiva should be done at the time of tumor excision to 
determine the extent of the disease and the degree of histologic atypia. Amniotic membrane 
transplantation may be used to restore the conjunctival surface following tumor excision, 
especially for large tumors in which the conjunctival defect is too large to close primarily. 
Amniotic membrane grafting reduces scarring and symblepharon formation, thereby 
improving postoperative cosmesis and ocular motility. Adjunct treatments are very useful 
postoperatively, especially for conjunctival melanoma in the setting of diffuse PAM with 
atypia. Cryotherapy, the historical standard of care for extensive PAM that cannot be 
completely removed surgically, can cause significant ocular surface morbidity when applied 
over a large area. Topical chemotherapy using mitomycin C has been shown to be effective, 
and in general, is well tolerated. It has the added advantage of treating the entire ocular 
surface, as opposed to cryotherapy, which treats only the areas to which it is applied. The 
optimal strength and duration of mitomycin C treatment has not been established in clinical 
trials. However, 0.02% to 0.04% eyedrops applied four times daily for 1- to 2-week cycles 
have been used with good success and minimal side effects. Serious complications from 
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mitomycin C use have occurred in other settings and one should approach this medication 
with caution. We wait until the ocular surface is completely healed following surgical 
manipulations before starting mitomycin C drops. Patients are cautioned to avoid contact of 
the medication with their skin, as it can cause contact dermatitis. Punctal plugs are placed in 
both the upper and lower punctum before beginning a course of mitomycin C and are 
replaced as needed during treatment to reduce systemic absorption. Manual punctal occlusion 
following each application of medication is an alternative to punctal plugs. We typically give 
0.04% mitomycin C drops for times daily for 1 week, followed by a 3-week holiday. Patients 
are examined prior to beginning the next course of mitomycin C. Usually two to three cycles 
are needed to see a reduction in conjunctival pigment. Conjunctival injection occurs almost 
universally, especially during later treatment courses. An ointment such as erythromycin or a 
steroid-antibiotic ointment combination can be given to soothe the eye. Refrigerated artificial 
tears and cold compresses may also be suggested. Map biopsies are repeated several months 
after the last course of mitomycin C to assess for residual disease. Orbital exenteration may 
be considered in aggressive, advanced, or bulky tumors especially if the eyelids and/or orbit 
are involved. This procedure, however, does not improve survival. Exenteration should not be 
performed in the elderly because of the associated morbidity in this population, or in cases in 
which distant metastasis have already occurred. Risk factors for exenteration included poor 
vision, amelanotic or red coloured tumor, and extralimbal tumor location. Conjunctival 
melanomas are not very radiosensitive. Iodine-125 brachytherapy, however, may be a useful 
alternative in patients who might otherwise require exenteration, or as an adjunct to surgical 
excision. Good local control was achieved with an average dose of 37 Gy. Proton beam 
therapy and beta irradiation are also other alternatives. 
Recurrences after treatment have been estimated to occur in 35% of patients, at an average of 
3.5 to 4.5 years after primary treatment. Patients with a history of conjunctival melanoma, 
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therefore, should be examined several times each year. Tumor recurrence is more common in 
melanomas arising from pre-existing PAM, in extralimbal lesions, and in multifocal tumors. 
Major risk factors for recurrence included nonlimbal location of the tumor and tumor cells at 
the margin after excision. Adjunctive cryotherapy decreases the chance of recurrences after 
surgical excision. Treatment of recurrent conjunctival melanoma is similar to the treatment of 
the primary tumor. Recurrent tumors may occasionally be nonpigmented, even if the original 
tumor was pigmented. Metastatic spread occurs in 16% of patients at 5 years, 26% at 10 
years, and 32% at 15 years. Metastasis occurs more commonly following recurrent 
melanoma. The prognosis is extremely poor after metastasis. These sobering statistics 
underscore the importance of accurate diagnosis and meticulous surgical and medical 
management of patients with conjunctival melanoma and primary acquired melanosis. 
DIFFERENTIAL DIAGNOSIS 
The differential diagnosis of primary melanocytic lesions of the conjunctiva includes 
secondary melanocytic lesions and nonmelanocytic pigmentary lesions. 
Addison’s disease and pregnancy may lead to conjunctival melanosis due to hormonal 
changes. 
Topical medications containing epinephrine products or silver and systemic medications such 
as the phenothiazines may lead to pigmentary deposits in the conjunctiva. 
After ocular surgical procedures. 
Congenital blue sclera and areas of scleral thinning from any cause may mimic primary 
pigmentary conjunctival lesions. 
Intraocular melanomas may extend to the conjunctiva or cornea, or conjunctival metastasis 
from the skin or other melanomas may occur. 
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REVIEW OF LITERATURE 
1.CONJUNCTIVAL BIOPSIES AND OPHTHALMIC LESIONS : A 
HISTOPATHOLOGIC STUDY IN EASTERN INDIA 
Conjunctiva is a thin and flexible mucus membrane that provides a protective barrier to the 
eye. Very few histopathological studies have been conducted on conjunctival biopsies in 
eastern India 120 cojunctival biopsies from 117 patients received during 8 years were 
included in the study. 
RESULTS : Histologic diagnosis were degenerative lesions in 38 cases, benign epithelial 
lesions in 23 cases ,premalignant and malignant epithelial lesions in 27 cases , melanocytic 
lesions in 10 cases , lymphoid in 7 cases and miscellaneous in 15 cases. 
CONCLUSION: 
Squamous papilloma was the commonest benign tumour whereas commonest malignant 
tumour was squamous cell carcinoma .melanocytic lesions were less prevalent compared to 
western studies. 
2.LYMPHOID LESIONS OF THE CONJUNCTIVA: RELATION OF 
HISTOPATHOLOGY TO CLINICAL OUTCOME 
JESSE SIGELMAN, MD FREDERICK A. JAKOBIEC, MD 
A retrospective clinicopathologic study of 40 patients with lymphoid lesions of the     
conjunctiva demonstrated the validity of current histologic criteria in predicting clinical      
outcome. Overall histologic architecture as well as cytologic detail must be used to 
differentiate benign reactive lymphoid hyperplasia from lymphoma. Lesions verified 
clinically as being malignant had obvious malignant cytologic features. Clinical signs of 
surface follicularity, multifocality, and minimal elevation suggest benignancy. All the benign 
lesions, on histopathologic examination, were either follicular in architecture or composed of 
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mature lymphocytes, and were generally restricted to the substantia propria. Bilaterality and 
clinical recurrence do not necessarily imply a malignant disease 
3. .MELANOCYTIC LESIONS OF CONJUNCTIVA 
Hardeep S Mudhar 
This article reviews the clinic pathological details of common benign and malignant 
melanocytic lesions of the conjunctiva .Melanocytic lesions clinically present as flat or 
nodular and it is in this way this review covers the commonest benign and malignant entities. 
Several types of naevi can be identified in the conjunctiva with some site specific 
peculiarities,familiarisation with which will allow a correct interpretation.Benign and atypical 
‘flat intraepithelial melanocytic lesions are covered in detail as they constitute many cases of 
referred material to specialist ophthalmic pathologists .The various classification schemes for 
atypical intraepithelial melanocytes are covered.Common histological and prognostic details 
for melanoma are mentioned.Ambuguous lesions are alluded to and how ancillary molecular 
investigations help in this regard along with a brief summary of the recent advancements in 
the molecular biology for conjunctival melanomas. 
4. CLINICAL AND HISTOPATHOLOGICAL ANALYSIS OF CONJUNCTIVAL 
TUMOURS AT A TERTIARY CARE CENTRE IN INDIAN POPULATION 
Hemalatha Krishnamurthy, Manjuladevi N, Tanushree V, Venkategowda H.T4, Bharathi M, 
Archana S, Shivani Nayak, Valijwala Ehatesham Ul Hak 
The broad spectrum of conjunctival tumors ranges from non-neoplastic benign tumors to very 
aggressive malignancies, such as melanoma or Kaposi’s sarcoma which threat visual function 
and life of the patient. There is a relative paucity of large published studies documenting 
conjunctival lesions. In the Indian population, reported 46% of epithelial origin (benign, 
premalignant, and malignant neoplasm), degenerative lesions (14%), chronic non-specific 
inflammation (12%), melanocytic tumors (12%), and lymphoid tumors (6%). Squamous cell 
58 
 
carcinoma (20%), miscellaneous (22%), pterygium (10%), squamous papilloma (8%), and 
OSSN (8%). A review of a large series of conjunctival biopsy specimens from an adult US 
population documented the following distribution: inflammatory/degenerative lesions (12%), 
benign epithelial (2%), pigmented (53%), premalignant and malignant epithelial (11%), 
lymphoid (8%), miscellaneous (12%) and congenital lesions (2%). 
 
AIM: To study the clinical and histopathological features of conjunctival tumors at a tertiary 
care hospital in south Indian population. 
 In this study, 134 patients with conjunctival tumors followed between January 2009 and 
September 2010 were retrospectively reviewed. Clinical data were collected from medical 
records and analyzed. Of the 134 patients with conjunctival tumor, 80 were male (59.70%) 
and 54 were female (40.29%). The mean age of the134 patients was 35 years (range1to 95 
years). In our series, the most common diagnosis of 134 lesions were, nevus 18.66% (n=25), 
carcinoma in situ 10.44% (n=14), dysplasia 5.97%(n=8), squamous cell carcinoma(SCC) 
5.22% (n=7), haemangioma 3.73% (n=5), squamous papilloma 3.73%(n=5), limbal dermoid 
2.98%(n=4), malignant melanoma 1.49% (n=2) and lymphoma 0.74 %(n=1). 
CONCLUSION: Nevus was found to be the most common conjunctival benign tumor. Even 
though squamous cell carcinoma is a rare conjunctival malignant tumor, it may be 
encountered in younger male population. 
 
 
 
 
 
59 
 
DETAILED STUDY PROPOSAL 
AIMS AND OBJECTIVES: 
1. To analyse the importance of histopathological examination in confirming the diagnosis of 
various conjunctival lesions like ocular surface squamous neoplasia, malignant melanoma, 
granulomas. 
2. To analyse the clinical presentation of various conjunctival lesions 
3.  To differentiate between benign and malignant lesions histopathologically (for early 
diagnosis of malignancy) 
 
MATERIALS AND METHODS: 
1        All patients with conjunctival lesions should undergo a detailed slit lamp examination 
and photograph the lesion preoperatively 
2. In case of malignant lesions clinical staging of the lesion is done 
3. Basic blood investigations like – random blood sugar , bleeding time and clotting time 
should be done before procedure 
4. Informed written consent to be obtained from the patient 
5. Patient is admitted as inpatient in ophthalmology ward 
6. The procedure is done in  Eye OT under strict aseptic precautions under suitable 
anasthesia 
7. The eye is draped and speculum is applied and specimen is obtained with 11 blade 
and forceps and scissors from the base and edge of the lesion 
8. In case of doubtful malignant lesion cryotherapy has to be applied 
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9. In cases with large conjunctival lesions after excision leaving a large conjunctival 
defect – amniotic membrane graft should be done 
10. The specimen collected has to be sent in a sterile container with formalin and sent 
immediately to the pathology laboratory for the histopathological examination of the 
same. 
 
STUDY CONUCTED AT: 
Department of Ophthalmology, GRH, Madurai medical college 
 
STUDY DESIGN 
Cross Sectional study 
 
STUDY POPULATION: 
Patients attending Eye OPD, GRH with bulbar conjunctival lesions indicating excision to 
restore smooth ocular surface and HPE to determine the etiology 
INCLUSION CRITERIA: 
1. Consenting patients 
2. Age more than 12 years, of either sex 
3. Presenting with conjunctival lesions of bulbar conjunctive requiring excision and HPE. 
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EXCLUSION CRITERIA: 
1. Patients with infective conjunctival lesions like bacterial, chlamydial, viral, fungal, 
rickettsial, protozoal, parasitic, spirocheal conjunctivitis. 
2. Patients with bleeding diathesis 
3. Patients on anticoagulants 
4. Patients not consenting to participate in the study 
5. Patients less than 12 years of age. 
SAMPLE SIZE: 
A total number of 40 patients attending to the Eye OPD, GRH Madurai with bulbar 
conjunctival lesions requiring biopsy and HPE and satisfying the above inclusion and 
exclusion criteria were taken for the study. 
STUDY DURATION: 
Study is conducted for a period of 5 months. 
FINANCIAL SUPPORT: 
Nil 
ETHICAL CLEARANCE: 
Ethical committee approval letter obtained 
INFORMED CONSENT: 
Consent was obtained for all patients/ guardians involved in the study. Visual acuity and a 
detailed anterior and posterior segment examination was done 
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RESULTS AND INTERPRETATION 
STATISTICAL ANALYSIS: 
The data was analaysed with SPSS statistical software package ( version 16.0 SPSS Inc. 
Chicago ,USA).The distribution of the conjunctival lesions were analysed using chi square 
test and p value < 0.05 will be considered as statistically significant. 
OBSERVATIONAL ANALYSIS 
TABLE 1: AGE DISTRIBUTION OF CONJUNCTIVAL LESIONS 
Among the 40 patients of the study group 12 were less than 20 years, 4 were between 21-40 
years, 13 were between 41 – 60 years and 11 were more than 60 years. 
Age in years No.of cases Percentage 
< 20 12 30% 
21 - 40 4 10% 
41 - 60 13 32.5% 
>  60 11 27.5% 
Total 40  
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AGE DISTRIBUTION
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TABLE 2: AGE DISTRIBUTION OF CONJUNCTIVAL LESIONS BASED ON 
HISTOPATHOLOGICAL DIAGNOSIS 
 
 
 
Age in years 
Benign 
Non 
pigmented 
Pre 
malignant-
non 
pigmented 
Malignant-
nonpigmented 
Benign 
pigmented 
Malignant 
pigmented 
premalignant 
Pigmented Cyst Degeneration 
< 20 4 0 1 4 1 0 2 0 
21 - 40 3 0 0 0 0 0 1 0 
41 - 60 2 3 2 0 1 0 1 4 
>  60 1 0 3 0 1 1 0 5 
Total 10 3 6 4 3 1 4 9 
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TABLE 3: PERCENTAGE DISTRIBUTION OF VARIOUS CONJUNCTIVAL 
LESIONS 
Among 40 patients, 25% cases were non pigmented benign lesions, 22.5% were degeneration 
,15 % were nonpigmented malignant lesions, 10 % were benign pigmented lesions, 10% were 
cysts , 7.5% were  nonpigmented premalignant lesions, 5% were premalignant pigmented 
lesions and 5% were malignant pigmented lesions. 
 
Diagnosis No.of cases Percentage 
Benign non pigmented 10 25 
Premalignant non pigmented 3 7.5 
Malignant non pigmented 6 15 
Benign pigmented 4 10 
Malignant pigmented 2 5 
Premalignant pigmented 2 5 
Cyst 4 10 
Degeneration 9 22.5 
Total 40 100 
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TABLE 4:  SEX DISTRIBUTION OF CONJUNCTIVAL LESIONS 
Among the study group of 40 patients, 23 were males and 17 were females. 
 
Sex 
No.of 
cases 
Percentage 
Male 23 57.5% 
Female 17 42.5% 
Total 40  
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TABLE 5: SEX DISTIBUTION BASED ON THE HISTOPATHOLOGICAL 
DIAGNOSIS: 
Among the 40 cases the following sex distribution was noted 
 
Sex 
Benign 
nonpigmented 
Pre 
malignant 
non 
pigmented 
Malignant 
non 
pigmented 
Benign 
pigmented 
Malignant 
pigmented 
premalignant 
Pigmented Cyst Degeneration 
Male  (23) 3 3 4 2 2 2 2 5 
Female (17) 7 0 2 2 0 0 2 4 
Total 10 3 6 4 2 2 4 9 
 
57%
43%
SEX DISTRIBUTION
Male
Female
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TABLE 6:  DISTRIBUTION OF CONJNCTIVAL LESION BASED ON 
LATERALITY 
Among the study group of 40 cases , in 13 cases right eye was involved and in 1 cases left 
eye was involved and in 11 cases both eyes were involved. 
Laterality 
No.of 
cases 
Percentage 
Right eye 13 32.5% 
Left eye 16 40% 
Both eye 11 27.5% 
Total 40  
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TABLE 7: DISTRIBUTION OF CONJUNCTIVAL LESIONS BASED ON THEIR 
GROSS FEATURES: 
Among the study group of 40 cases the following range of gross features were noted the most 
common being pinkish lesion. 
Gross features No.of cases 
Pinkish 13 
Yellowish 8 
Brownish 5 
Whitish 4 
Flat pigmented 3 
Leucoplaciform 2 
Reddish 1 
Salmon 2 
Soft 1 
Transparent 1 
Total 40 
 
13
16
11
SIDE
Right eye
Left eye
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Consistency/ 
colour 
Benign 
non 
pigmented 
Pre 
malignant 
non 
pigmented 
Malignant 
Non 
pigmented 
Benign 
pigmented 
Malignant 
pigmented 
premalignant 
Pigmented Cyst 
Degene 
ration 
Pinkish 4 0 1 0 0 0 2 6 
Yellowish 3 0 0 0 0 0 0 3 
Brownish 0 0 0 3 1 1 0 0 
Whitish 0 3 1 0 0 0 0 0 
Flat pigmented 0 0 0 1 1 1 0 0 
Leucoplaciform 0 0 2 0 0 0 0 0 
Reddish 1 0 0 0 0 0 0 0 
Salmon 0 0 2 0 0 0 0 0 
Soft 0 0 0 0 0 0 1 0 
Transparent 0 0 0 0 0 0 1 0 
Total 8 3 6 4 2 2 4 9 
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TABLE 8: SMOKING VS CONJUNCTIVAL LESIONS: 
Among the study group 27.5% cases are smokers, among which all were males.Among the 
males 47.8% were smokers. And it is found that there is a high preponderance of malignant 
and premalignant (both pigmented and non-pigmented) among the smokers. 
 
 
 
Smoking 
Benign 
non 
pigmented 
Pre 
malignant 
non 
pigmented 
Malignant 
non 
pigmented 
Benign 
pigmented 
Malignant 
pigmented 
premalignant 
Pigmented Cyst Degeneration 
Present 1 2 4 0 1 1 0 2 
Absent 9 1 2 4 1 1 4 7 
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TABLE 9:  PRESENCE OF SCLERAL FIXITY IN THE CONJUNCTIVAL LESIONS 
Among the study group of 40 cases, scleral fixity was absent in 31 cases, present in 7 cases 
and minimal in 2 cases. 
SCLERAL 
FIXITY 
No.of 
cases 
Present 7 
Absent 31 
Minimal 2 
Total 40 
 
 
 
7
31
2
SCLERAL FIXITY VS DIAGNOSIS
Present Absent
Minimal
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TABLE 10 : DISTRIBUTION OF SCLERAL FIXITY AMONG VARIOUS 
CONJUNCTIVAL LESIONS BASED ON HISTOPATHOLOGICAL DIAGNOSIS 
Among the 40 cases in study group, it was noted that scleral fixity was associated with 
malignant lesions (pigmented / non pigmented) and chi square test was used and the p value 
was found to be 0.029 which was significant. 
Scleral Fixity 
Benign 
non 
pigmented 
Pre 
malignant 
non 
pigmented 
Malignant 
non 
pigmented 
Benign 
pigmented 
Malignant 
pigmented 
premalignant 
Pigmented Cyst Degeneration 
Present   (7) 0 1 4 0 2 0 0 0 
Absent  (31) 10 0 2 4 0 2 4 9 
Minimal  (2) 0 2 0 0 0 0 0 0 
Total 10 3 6 4 2 2 4 9 
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TABLE 11: DISTRIBUTION OF CONJUNCTIVAL LESIONS BASED ON THE 
NUMBER OF CONJUNCTIVAL LESIONS 
Among the study group of 40 cases around 36 cases were having single lesion, 2 cases had 2 
lesions, and 2 cases had single large lesion involving 3-4 clock hours. 
Lesion No.of cases 
1 36 
2 2 
INVOLVING 3 & 4 CLOCK HOURS 2 
Total 40 
 
TABLE 12: NUMBER OF CONJUNCTIVAL LESIONS VS HISTOPATHOLOGICAL 
DIAGNOSIS OF LESION 
Among the study group of 40 cases the following distribution of conjunctival lesions based 
on number of lesions and histopathological diagnosis was noted. 
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Lesion 
Benign 
non 
pigme
nted 
Pre 
maligna
nt non 
pigment
ed 
Malignant 
non 
pigmented 
Benign 
pigmented 
Malignant 
pigmented 
premalignant 
Pigmented Cyst Degeneration 
1 9 3 6 3 2 0 4 9 
2 1 0 0 1 0 0 0 0 
INVOL
VING 3 
& 4 
CLOCK 
HOURS 0 0 0 0 0 2 0 0 
Total 10 3 6 4 2 2 4 9 
 
 
TABLE 13:  DISTRIBUTION OF CONJUNCTIVAL LESIONS BASED ON SIZE: 
Among the study group of 40 cases 25 cases were <3 mm and 15 cases were 4-7 mm in size. 
 
Size of lesions 
No.of 
cases 
2- 3 mm 25 
4 - 7 mm 15 
Total 40 
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TABLE 14: DISTRIBUTION OF VARIOUS CONJUNCTIVAL LESIONS BASED ON 
HISTOPATHOLOGICAL DIAGNOSIS AND SIZE: 
Among the study group of 40 cases following pattern of distribution was noted based on the 
size. 
Size of lesions 
Benign 
non 
pigmented 
Pre 
malignant 
non 
pigmented 
Malignant 
non 
pigmented 
Benign 
pigmented 
Malignant 
pigmented 
premalignant 
Pigmented Cyst Degeneration 
2- 3 mm  (25) 9 0 2 4 0 0 4 6 
4 - 7 mm  (15) 1 3 4 0 2 2 0 3 
Total  (40) 10 3 6 4 2 2 4 9 
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TABLE 15:  DISTRIBUTION OF CONJUNCTIVAL LESIONS BASED ON THEIR 
MANAGEMENT: 
Among the 40 cases in the study group 10 cases underwent 3 mm tumour free margin 
excision. 
Type of Biopsy No.of cases 
Excision 30 
Excision with  3mm free margin 10 
Total 40 
 
TABLE 16: DISTRIBUTION OF CONJUNCTIVAL LESIONS BASED ON THEIR 
HISTOPATHOLOGICAL DIAGNOSIS AND THE TYPE OF BIOPSY DONE: 
Among the 40 study cases the management was done as follows for various lesions. It was 
noted that 3 mm tumour free margin was excised for malignant cases most commonly. 
Type of Biopsy 
Benign 
non 
pigmented 
Pre 
malignant 
non 
pigmented 
Malignant 
non 
pigmented 
Benign 
pigmented 
Malignant 
pigmented 
premalignant 
Pigmented Cyst Degeneration 
Excision  (30) 10 0 1 4 0 2 4 9 
Excision with 3mm 
tumour free margin 
(10) 0 3 5 0 2 0 0 0 
Total 10 3 6 4 2 2 4 9 
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TABLE 17:  DISTRIBUTION OF CONJUNCTIVAL LESIONS BASED ON THE 
DURATION OF THE LESION: 
Among the study group of 40 cases 17 cases were present for < 1 year duration, 10 cases 
were present for 1-3 years duration, and 13 cases were present for a duration of > 3 years. 
Duration of 
lesions 
No.of 
cases 
<  1 year 17 
1 - 3 years 10 
> 3 years 13 
Total 40 
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TABLE 18: DISTRIBUTION OF CONJUNCTIVAL LESIONS BASED ON 
HISTOPATHOLOGICAL DIAGNOSIS AND DURATION OF THE LESIONS: 
Among the study group of 40 cases the following pattern of distribution was noted depending 
on the duration of lesion. 
Duration of lesions 
Benign 
non 
pigmented 
Pre 
malignant 
non 
pigmented 
Malignant 
non 
pigmented 
Benign 
pigmented 
Malignant 
pigmented 
premalignant 
Pigmented Cyst Degeneration 
<  1 year  (17) 5 3 4 0 2 0 3 0 
1 - 3 years  (10) 3 0 2 1 0 0 0 4 
> 3 years (13) 2 0 0 3 0 2 1 5 
Total 10 3 6 4 2 2 4 9 
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TABLE 19: DISTRIBUTION OF CONJUNCTIVAL LESIONS BASED ON THE 
CORNEAL INVOLVEMENT: 
Among the 40 study group cases corneal involvement was present in 7 cases and absent in 33 
cases. 
Corneal 
involvement 
Benign 
non 
pigmented 
Pre 
malignant 
non 
pigmented 
Malignant 
non 
pigmented 
Benign 
pigmented 
Malignant 
pigmented 
premalignant 
Pigmented Cyst Degeneration 
Present   (7) 2 0 1 0 0 1 0 3 
Nil  (33) 8 3 5 4 2 1 4 6 
Total 10 3 6 4 2 2 4 9 
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TABLE 20: DISTRIBUTION OF CONJUNCTIVAL LESIONS BASED ON PAIN: 
Among the study group of 40 cases the following pattern of distribution was noted. 
Pain 
Benign 
non 
pigmented 
Pre 
malignant 
non 
pigmented 
Malignant 
non 
pigmented 
Benign 
pigmented 
Malignant 
pigmented 
premalignant 
Pigmented Cyst Degeneration 
Mild    2 2 1 0 1 0 2 0 
Mild on 
and off  0 0 0 0 0 0 0 1 
Moderate  1 0 2 0 1 0 0 0 
Nil   7 1 3 4 0 2 2 8 
Total 10 3 6 4 2 2 4 9 
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TABLE 21: DISTRIBUTION OF CONJUNCTIVAL LESIONS BASED ON 
PROGRESSION 
Among the 40 study cases progression was noted in 28 cases and absent in 12 cases. 
 
 
 
 
 
TABLE 22: DISTRIBUTION OF CONJNCTIVAL LESIONS BASED ON 
HISTOPATHOLOGICAL DIAGNOSIS AND PROGRESSION: 
 
Progression 
Benign 
non 
pigmented 
Pre 
malignant 
non 
pigmente
d 
Malignan
t non 
pigmente
d 
Benign 
pigmente
d 
Maligna
nt 
pigmente
d 
premaligna
nt 
Pigmented Cyst 
Degenerati
on 
Present 4 3 5 3 2 2 1 8 
Absent 6 0 1 1 0 0 3 1 
Total 10 3 6 4 2 2 4 9 
 
 
Progression No.of cases 
+ 28 
- 12 
Total 40 
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TABLE 23:  DISTRIBUTION OF CONJUNCTIVAL LESION BASED ON NATURE 
OF DISEASE 
Among the 40 cases studied only 2 were congenital others were acquired. 
 
Benign 
non 
pigmented 
Pre 
malignant 
no 
 
n 
pigmented 
Malignant 
non 
pigmented 
Benign 
pigmented 
Malignant 
pigmented 
premalignant 
Pigmented Cyst Degeneration 
ACQ  (38) 9 3 6 4 2 2 3 9 
CONG  (2) 1 0 0 0 0 0 1 0 
Total  (40) 10 3 6 4 2 2 4 9 
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TABLE 24: DISTRIBUTION OF CONJUNCTIVAL LESIONS BASED ON 
ADDITIONAL MANAGEMENT DONE AFTER EXCISION BIOPSY: 
Among the 40 cases studied additional intervention was done for 19 cases. Cryotherapy with 
amniotic membrane graft was done for 9 cases, conjunctival autograft was done for 8 cases, 
plain amniotic membrane graft was done for 1 case and alcohol ablation of cornea was done 
for 1 case.It was noted that all malignant cases underwent cryotherapy with AMG 
Additional Management No.of cases 
CONJ AUTOGRAFT 8 
CRYOTHERAPY WITH AMG 9 
AMG 1 
CRYOTHERAPY WITH AMG,CORNEA- ALCOHOL ABLATION 1 
Nil 21 
Total 40 
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Benign 
non 
pigmented 
Pre 
malignant 
non 
pigmented 
Malignant 
non 
pigmented 
Benign 
pigmented 
Malignant 
pigmented 
premalignant 
Pigmented Cyst Degeneration 
CRYO WITH AMG 
=/- CORNEAL 
ABLATION (10) 0 3 5 0 2 0 0 0 
AMG (1) 0 0 0 0 0 0 0 1 
CONJ 
AUTOGRAFT(8) 3 0 0 0 0 2 0 3 
NIL (21) 7 0 1 4 0 0 4 5 
Total  (40) 10 3 6 4 2 2 4 9 
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TABLE 25:  DISTRIBUTION OF CONJUNCTIVAL LESIONS AND OCULAR 
ASSOCIATIONS 
Among the 40 cases studied various ocular associations have been identified as follows 
OCULAR ASSOCIATION NO.OF CASES 
Cataract 3 
BE -Cataract 5 
BE - PCIOL With Diabetic Retinopathy 2 
BE PCIOL 3 
H/O Trauma 4 
H/O Cataract Surgery Re- F/B H/O Trauma 1 
Corneal Pigmentation 1 
RE PCIOL, LE - Cataract 1 
LE- Neurofibroma Of Lid,,Mild Sphenoid Dysplasia ,BE - Lisch Nodules 1 
PCIOL 1 
Cataract , Lepra Nodule In Iris 1 
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TABLE 26: DISTRIBUTION OF CONJUNCTIVAL LESION AND THEIR 
RECURRENCE: 
Among the study group of 40 cases 3 cases were recurrent and chi square test showed the 
association between the malignant lesion and recurrence with p value 0.029 which is 
significant. 
 
Recurrence 
Benign 
non 
pigme
nted 
Pre 
malignant 
non 
pigmented 
Malignant 
non 
pigmented 
Benign 
pigmented 
Malignant 
pigmented 
Premalignant 
Pigmented 
Cys
t 
Degenera
tion 
Present 0 0 1 0 2 0 0 0 
Absent 10 3 5 4 0 2 4 9 
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SUMMARY: 
• In this study, 40 patients participated and the conjunctival biopsies were sent for the 
histopathological analysis. The following observations were made. 
• Among them, 30% were < 20 years, 10% between 21-40 years, 32.5% between 41-60 
years, and 27.5% more than 60 years. 
• It was noticed that benign non pigmented tumours and benign pigmented lesions are 
more common in less than 40 years. 
• In more than 60 years, degenerations and malignancies are more common 
• Among the distribution of various lesions based on their histopatholoical diagnosis – 
benign non pigmented tumours are most common around 25%, degenerations are 
second most common – 22.50%.Third most common includes non-pigmented 
malignant lesions 15%. 
• Among the benign non pigmented tumours –squamous papilloma (33%) is most 
common and among degeneration- pterygium (33%) and pingecula (33%) are most 
common .Among malignancies – squamous cell carcinoma (37.5%) is most common. 
• In this study 42.5% were females and 57.5% were males.It was noted that there is a 
markedly high percent of malignant (75%) and premalignant (100%) lesions in males 
than females. 
• There is no significant predilection of laterality of eyes in conjunctival lesions 
• The most common site for conjunctival lesions is the bulbar conjunctiva (87.5%) 
• In this study, from the gross features of conjunctival lesions indicates that non 
pigmented malignancies most often (50%)are leukoplakic white growth and benign 
non pigmented lesions are most often (46%) pinkish in colour 
• In this study it was noted that scleral fixity of the lesion is associated with malignancy 
most commonly ( 85%) and it was statistically significant with p value of 0.029 
88 
 
• In this study there were 27.5% smokers and all of them were males. Among males 
47.8% were smokers (11 patients), Among the 11 patients 3 lesions were 
premalignant and 5 lesions were malignant, which constitutes about 72%. In this 
study 2 patients with OSSN were also PLWHA. CIN, lymphoma, metastatic lung 
cancer could have been because of its association with smoking. 
• From the study it is  noted that the number of lesions does not conclude the nature of 
the lesion 
• In the study it is obvious that larger the lesion size >4mm it is more likely to be 
malignant or premalignant (73%) and most smaller lesions <3mm are benign (36%) 
• It was also concluded that all malignant lesions need wide excision with tumour free 
margin of about 3 mm (70%) and also additional application of cryotherapy and AMG 
(70%) 
• From the study it was noted that chronic lesions >3 years are more likely to be either 
degenerative (38%) or benign (38%) 
• In this study it is seen that the presence of corneal involvement in conjunctival lesions 
does not conclude the nature of the lesion. 
• In this study it is found out that pain is commonly associated with any type of 
malignant lesions (38.4%) and mild pain may be a feature of traumatic granuloma or 
inclusion cysts (30%) 
• It is noted that progression is characteristically absent in benign lesions (50%) 
• It is also noted that acquired lesions are more common (95%) than congenital lesions 
(5%) 
• It is also found that most OSSN are associated with HIV (50%) 
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• From the study it was found that visual acuity cannot be correlated with the severity 
of the lesion because of lot of confounding factors like refractive error, cataract and 
diabetic retinopathy in these patients with conjunctival lesions 
• In this study it is found that recurrence after excision is markedly associated with 
malignant lesions (pigmented/ non pigmented) (30%) and it was found to be 
statistically significant with p value of 0.029. 
 
DISCUSSION: 
Tumours of the conjunctiva have large spectrum that range from benign to aggressive life and 
vision threatening malignancies. The conjunctiva spawns neoplastic lesions from both its 
epithelial & stromal structures. Conjunctiva being visible, tumours and lesions that occur are 
easily recognized at a relatively early stage. Tumours having typical clinical features and 
small benign appearing tumours do not need a biopsy usually. If a smaller tumour does 
require a biopsy, it is often better to completely remove the lesion, by excisional biopsy. In 
cases of larger lesions, however, it is appropriate to remove a portion of the tumour 
(incisional biopsy) to obtain a histopathologic diagnosis before embarking on more extensive 
therapeutic approach. 
In a study by Hemalatha Krishnamurthy, Manjuladevi N on the clinical and histopathological 
analysis of conjunctival tumours in tertiary care centre in Indian population showed that 
(59.70%) patients were male and (40.29%) patients were female. The mean age of the134 
patients was 35 years. (76.12%) were benign, (5.97%) were premalignant and (17.91%) were 
malignant cases. 
The most common diagnosis of 134 conjunctival lesions were, nevus 18.66%, chronic 
inflammation 15%, followed by foreign body granuloma 13.4% , carcinoma in situ 10.44% , 
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Squamous cell dysplasia 5.97%, tendons cyst 5.97% , squamous cell carcinoma (SCC) 5.22% 
, epithelial cysts 5.22%, dermolipoma in 4.48, haemangioma 3.73% , squamous papilloma 
3.73%, dermoid 2.98, pyogenic granuloma 2.98%,malignant melanoma 1.49% and 
lymphoma 0.74 % 
The most common indication for resection of tumour was suspected growth of the tumour. In 
all cases of suspected growth, the tumour was excised surgically, (1.49%) SCC was treated 
with topical mitomycin C after tumour resection. Malignant lesions had no systemic 
metastasis and local recurrence. 
 
Amoli and Heidari reported that the most common benign primary conjunctival tumour was 
nevus 38.7% (mean age of the patients 22.27) and the most common malignant tumour 
(25.1%) was SCC (mean age of the patients 58.63) in their series 
Shield et al reported a change in tumour colour detected in 13% and a change in tumour size 
detected in 8% from his study. Regarding the symptoms and clinical appearance of the 
conjunctival nevus, most patients reported noticing a spot on the eye (65%), 5% noted 
inflammation, and 30% of patients were unaware of the lesion. The symptoms were present 
for a mean of 12 years. Enlargement or colour change in the lesion over the years prior to our 
examination was reported by 54% of patients, but support for such enlargement was rarely 
photographed. 
The tumour was most commonly found in the bulbar conjunctiva (79%), caruncle (18%), or 
plica semilunaris (3%). 
Shield et al reports conjunctival nevus found most commonly in the bulbar conjunctiva 
(72%), caruncle (15%), or plica semilunaris (11%). Rarely was the tumour found in the 
fornix (1%), tarsal conjunctiva (1%), or within the cornea (1%). It has been suggested that the 
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presence of a nevus in the palpebral and forniceal region should raise the suspicion of 
malignancy and early biopsy. 
In a Danish study by Gerner et al provided a clinicopathologic study on 343 conjunctival 
nevi. They described the following tumour locations: the bulbar conjunctiva in 33% caruncle 
in 29%, limbal conjunctiva in 27%, and at the eyelid margin in 1% 
In our study group the most common lesion isolated was benign pigmented and 
nonpigmented lesions were common in < 40 years and in >60 years degenerative and 
malignancies are common. 
Overall the most common lesion was squamous papilloma followed by degenerative lesions 
like pterygium and pingecula and thirdly squamous cell carcinoma. This difference is due to 
the geographic variation in the study group. 
In this study also the most common location of the conjunctival lesions was bulbar 
conjunctiva. The indication for conjunctival biopsy is ambiguity of clinical diagnosis and 
cosmetic blemish. Also in our study OSSN was markedly associated with HIV.Also OSSN, 
CIN, lymphoma, conjunctival metastasis of lung cancer has been found to be associated with 
smoking. 
Most patients included in the study group experienced no symptom other than cosmetic 
blemish due to visible conjunctival mass but few malignant and traumatic granuloma and 
inclusion cyst patients had mild – moderate pain. Also it was concluded that scleral fixity and 
recurrence are most common in malignancies. 
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CONCLUSION 
It is observed that in subjects below 50 years benign non pigmented lesions like squamous 
papilloma are common and they are asymptomatic, mostly <3mm size , freely mobile , have a 
chronic course and do not recur after simple excision.  
It is also observed that in subjects > 50 years in our study the malignant lesion like squamous 
cell carcinoma are more common and have predilection towards males.They have pain, 
grossly appear leucoplakic ( in malignant non pigmented lesions),> 4mm size mostly and 
scleral fixity is present. They require cryo therapy and AMG after excision and they recur 
often after excision. It was also observed that the smokers had more incidence of 
premalignant- malignant lesions and OSSN was seen more in HIV positive patients.
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LIST OF ABBREVATIONS  
OSSN – Ocular Surface Squamous Neoplasia 
PAM – Primary Acquired Melanosis 
RT – Radiotherapy 
AD – autosomal dominant , AR – autosomal recessive 
CGy – Centi Gray 
5-FU- 5 Fluoro uracil 
MM C – Mitomycin C 
PLWHA – People living with HIV AIDS 
LIST OF ABBREVATIONS FOR MASTER CHART 
ART – Anti retroviral treatment (for HIV) 
ACQ – acquired 
CONG – congenital 
CIN – Carcinoma in situ 
HPE – Histopathological examination 
HIV – Human immunodeficiency virus 
AMG – Amniotic membrane graft 
RE –Right eye LE – Left eye BE – Both eye 
PCIOL- Posterior chamber intraocular lens 
DR – Diabetic retinopathy 
CONJ – Conjunctiva 
LN – lymph node enlarged 
CA- carcinoma 
C - Cataract 
K/C/O – Known case of 
SIZE <3 mm –S 
>4 mm –L 
A- Absent 
P- Present 
M-Minimal 
Group 1 - <1 year duration 
Group 2 – 1-3 years duration 
Group 3 - >3 years duration 
BC – Bulbar conjunctival location 
FC – Forniceal conjunctival location 
MC – Medial canthal location 
SF – Scleral fixity 
O – Occasional 
T- Trauma 
NF – Neurofibroma lid, Lisch nodule, sphenoid dysplasia 
LEP – Lepra nodule in iris 
E – Excision 
E+TFM –Excision with 3 mm tumour free margin 
BX – Biopsy 
CRYO +AMG- Cryotherapy with Amniotic membrane graft 
AUTO – Conjunctival autograft 
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